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ABSTRACT 
 
 Anxiety Disorders, in particular Generalised Anxiety Disorder, have escalated in 
incidence over the past decade resulting not only in additional burden for primary health care 
systems but also debilitating impacts on those who suffer from this constellation of 
conditions. It is relevant to note that, because Anxiety Disorders commonly coexist with 
other mental disorders (e.g., depression) and physical illnesses (e.g., cancer) as well as 
maladaptive coping behaviours (e.g., excessive alcohol/drug consumption), their 
psychotherapeutic treatment is not always straightforward. Presence of co-existing conditions 
not only leads to complex presentation of symptomatology but also limits the effectiveness of 
generic or manualised treatment approaches. Those treatment approaches, which are common 
in the mental health field, have been shaped by conceptualisation of anxiety-based diagnoses 
as labels that indicate homogeneity in symptoms as well as equivalence in impacts of those 
symptoms across individual clients. Therefore, whilst diagnostic manuals such as the DSM 
have been essential to promoting accurate diagnosis of Anxiety Disorders, they do not 
provide a sound basis for the type of idiographic assessment that would facilitate 
individualised treatment planning. Therefore the issues of 1) how an idiographic assessment 
might be tailored to the investigation of anxiety and 2) how idiographic assessment data 
might be used to administer an intervention to remediate the somatic symptoms of anxiety 
require further examination. 
 This study examined the capacity of a Functional Assessment process tailored to the 
investigation of Generalised Anxiety Disorder to generate additional data to facilitate detailed 
understanding of anxiety behaviour (symptoms) and the impact of these behaviours on day-
to-day functioning. This Functional Assessment process was also evaluated in relation to its 
capacity to determine the factors responsible for strengthening anxiety responses. The 
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assessment process under investigation was applied individually to 11 adult participants with 
a diagnosis of Generalised Anxiety Disorder thus allowing for an n = 1 evaluation of 
individual cases as well as a comparative examination of group results. Findings suggested 
that the Functional Assessment succeeded in recording data which described behaviour-
environment interactions in detail. 
 This study also evaluated the effects of a seven-session Biofeedback plus behavioural 
training intervention on anxiety level in the same group of 11 participants. The focus of this 
intervention was on anxiety reduction via greater participant awareness of physiological 
functions (i.e., Heart Rate and Respiratory Sinus Arrhythmia) and cumulative control over 
those functions. Change in anxiety level was established at pre-and-post intervention (i.e., 
self-report anxiety scale responses and Heart Rate plus Respiratory Sinus Arrhythmia 
measures) as well as during intervention (i.e., session-by-session measurement of Heart Rate 
and Respiratory Sinus Arrhythmia). The intervention was administered individually to each 
participant and results are reported in relation to n = 1 and group evaluations. Findings 
indicated that the intervention was effective in reducing anxiety level across all participants. 
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CHAPTER 1 
Introduction 
 Anxiety is ubiquitous in modern society and recent estimates suggest that most people 
will experience some form of anxiety at some stage of their lives (Greenberg et al., 1999). 
This escalation in anxiety has resulted in the need for effective and time-efficient procedures 
for accurate identification and targeted treatment of Anxiety Disorders. Simon, Ormel, Von 
Korff, and Barlow (1995) have argued for tailored treatments to be applied as close to anxiety 
onset as possible to minimise exacerbation of any co-existing mental health problems and use 
of maladaptive coping behaviours used by suffers to reduce the emotional and somatic 
discomfort that is embedded in an Anxiety Disorder. This delivery of early and targeted 
interventions rest on accurate diagnosis of Anxiety Disorders, clear understanding of how this 
disorder manifests itself in day-to-day life and what constitutes effective intervention.  
 The DSM-IV-TR (APA, 2000) contains diagnostic criteria for eleven Anxiety 
Disorders with Generalised Anxiety Disorder (GAD) representing the most frequently made 
diagnosis among primary practitioners such as general practitioners and specialist clinicians 
(i.e., Psychiatrists and Clinical Psychologist). This disorder is particularly debilitating as it is 
associated with intense feelings of fear which, even if they initially relate to a specific event, 
pervade across most events and contexts in the person‘s life (Beyond Blue, 2013). Therefore, 
on the bases of incidence and disruption to functioning, GAD is worthy of further and 
focused investigation. The DSM-IV-TR (APA, 2000) provides clear criteria to assist in the 
diagnosis of GAD from a labelling perspective but, if the challenge is delivery of targeted 
treatment to remediate specific difficulties, then the assessment process needs to extend 
beyond the use of this diagnostic manual. One framework for understanding the particular 
experiences and needs of people with the same diagnosis is Functional Assessment which has 
a strong history in the research literature as a process for collecting individualised data on 
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behaviour (symptoms) for the purpose of intervention planning (Bitsika, 2005). Despite 
application of Functional Assessment to diagnostic categories such as depression, Anorexia 
Nervosa, and school refusal, there have been very few uses of this process in Anxiety 
Disorders. Therefore, the question of what constitutes a Functional Assessment process 
tailored for GAD is worthy of investigation. 
 Psychotherapeutic treatment to assist with mental disorders has been shaped 
substantially by the push for use of evidence-based methods which have been submitted to 
evaluation in scientific research (Burns, Hoagwood & Mrazek, 1999). This push has had the 
distinct advantages of removing questionable treatments from use in the field and providing a 
uniform (via delivery of manualised treatments) method for treating disorders. However, 
manualised treatments have also been criticised for being label- rather than person-focused 
and generic in nature leading to lack of focus on individual experiences and life 
circumstances (Bitsika, 2003). Therefore, the need for targeted intervention (to the person 
and his/her life experiences) is increasing and one possible avenue for meeting this need is 
investigation of treatment that adhere to the criteria for being evidence-based and which take 
into account the factors which impact the individual‘s particular experiences and 
circumstances. 
 Chapter 2 of this thesis discusses the defining features of GAD and differentiates this 
condition from the other Anxiety Disorder diagnoses in the DSM-IV-TR (APA, 2000). The 
major inter-disciplinary frameworks (i.e., psychological, functional analytic, and medical) for 
conceptualising anxiety are described and contrasted in order to illustrate practitioner 
differences in understanding anxiety impacts and developing treatment to remediate those 
impacts. This thesis is written from the perspective that anxiety-based disturbance is in large 
part attributable to somatic symptoms thus setting the foundation for treatment which directly 
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targets physiology. This thesis is also oriented towards trialling person-centred methods for 
assessing clients with GAD. 
 Chapter 3 of this thesis presents a framework for post-diagnosis, person-centred 
assessment of anxiety (i.e., Functional Assessment). Functional Assessment is discussed in 
relation to its evolution over the past 30 years, the key data-recording and data-interpretation 
methods it applies, and some possible reasons for why it has not been used to investigate 
anxiety. This chapter also presents a model, based on key findings from the literature, for 
adapting Functional Assessment to GAD and provides an outline for how this model was 
applied to investigate the experiences of the participant group for this study. 
 Chapter 4 of this thesis discusses Biofeedback Training as an evidence-based 
treatment which specifically targets the somatic symptoms of mental disorders. Biofeedback 
Training is reviewed from an historical perspective which suggests that its initial uses 
focused on physical conditions to discussion of contemporary applications designed to assist 
with reduction of somatic symptoms associated with mental disorders. The pitfalls of using of 
Biofeedback Training to treat poorly defined or ill-suited conditions (to this treatment 
modality) are addressed with reference to objective criteria for what constitutes evidence-
based Biofeedback Training. 
 Chapter 5 of this thesis presents the procedures used to conduct a Functional 
Assessment of GAD and deliver a Biofeedback plus Behavioural Training intervention. The 
Functional Assessment provided the basis for idiographic investigation of GAD as a fear 
response, it also aimed to identify those antecedent factors associated with occurrences of the 
fear response and consequent events thought to strengthen that response and cause it to 
become pervasive. The Biofeedback plus Behavioural Training intervention consisted of 
seven individually-administered sessions which involved use of Heart Rate and Respiratory 
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Sinus Arrhythmia as the physiological indicators for anxiety. Those responses were used to 
provide participants with feedback on their capacity to create physiological change whilst 
engaging in a behavioural strategy.  
 Chapter 6 of this thesis discusses the findings obtained from the trial application of 
the Functional Assessment process for GAD and the implementation of the Biofeedback and 
Behavioural Training intervention. The major findings relating to the Functional Assessment 
process indicate that it did produce greater breadth and depth of information on anxiety 
experiences than would not be possible from a DSM-IV-TR (APA, 2000) diagnosis. That 
information was particularly relevant to understanding the factors which caused escalation in 
anxiety and the ways in which that aversive mood state had become an adaptive response. 
The evaluation of the Biofeedback and Behavioural Training intervention showed that 
participants were able to learn to control their physiological reactivity (i.e., Heart Rate and 
Respiratory Sinus Arrhythmia) to reduce somatic as well as cognitive/emotional anxiety. 
Findings suggest that participants were able to learn a number of behavioural strategies for 
reducing anxiety which they were able to apply to their day-to-day lives. 
 Chapter 7 of this thesis reviews the key findings in relation to the literature to 
comment on the possible contributions of the current study to the broader clinical field. The 
implications for incorporating Functional Assessment to person-centred investigation of 
anxiety in the Counselling context, as well as the relevance of Biofeedback Training to the 
treatment of the somatic and cognitive/emotional symptoms anxiety are also discussed. 
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CHAPTER 2 
Description of Anxiety 
 Anxiety Disorder is the most common form of ill mental health in adults and children 
(ABS, 2009). The Australian Bureau of Statistics (ABS) figures obtained from a 2007 survey 
indicated that anxiety affected approximately 14% of all Australians aged between 16-85 
years in the 12 months prior to that survey being conducted. Further, women were more 
likely to have experienced anxiety disorders than men (i.e., prevalence of 18% and 11% 
respectively). Data released by Beyond Blue (2013) indicate that Generalised Anxiety 
Disorder (GAD) is the most commonly-occurring diagnosis, and affects approximately 5 - 6 
percent of Australians at some time in their lives (Beyond Blue, 2013). The American 
National Institute of Mental Health (NIMH) (2010) published figures showing a lifetime 
prevalence of GAD of 5.7 percent in the US population, with some variation in relation to 
gender (i.e., prevalence of 7.1% in women and 4.2% in men) and life stage (i.e., 4.3% in 18-
29 year olds; 6.5% in 30-44 year olds; 7.6% in 45-59 year olds; 4.0% in 60+ year olds). 
Wittchen and Hoyer (2001), in their review of lifetime prevalence of GAD across countries, 
suggested that the prevalence of GAD can be as high as 21.7 percent (Iceland) and as low as 
0.5 percent (Germany). Findings such as these clearly indicate that anxiety poses a substantial 
threat to adaptive functioning across the age span. 
  The most prominent subgroup of anxiety is GAD. A review of categorical 
descriptions of anxiety and its subtypes, from historical and more recent perspectives, is 
presented below to make explicit the diagnostic criteria which facilitate its identification and 
adverse impacts on adaptive functioning.  
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2.1 Categorical Descriptions of Anxiety 
 The term anxiety has a long history in the psychiatric field and was first described as a 
form of neurosis by William Cullen in 1769 (Knoff, 1970), being described as a mental 
disorder which caused suffers to experience deterioration in behavioural functioning (within 
acceptable social norms) and no onset of delusions or hallucinations (Strachey, 1974). The 
broad Neurosis classification was also used in the first and second editions of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM) (titled respectively DSM-I [APA, 1952] 
and DSM-II [APA, 1968]). These editions of the DSM presented the following five distinct 
neurosis-based diagnoses: Phobic Neurosis, Anxiety Neurosis, Obsessive-Compulsive 
Disorder, Hysterical Neurosis, and Depressive Neurosis. The term neurosis was dropped in 
the DSM-III (APA, 1980) and subsequent DSM-III-R (APA, 1987) and replaced with anxiety 
state in recognition of the fact that anxiety was considered an adaptive response which 
became problematic only with increases in intensity and frequency of symptoms (Brown, 
O‘Leary and Barlow, 2001). 
 Current categorical descriptions of anxiety, as described in the DSM-IV-TR (APA, 
2000) and the International Classification of Diseases - Tenth Edition (ICD-10, 1993), agree 
that anxiety is best conceptualised as a negative mood state which is characterised by somatic 
symptoms of tension and apprehension about the future. These broad features are further 
refined in relation to anxiety subgroup (or diagnosis) and the following discussion will focus 
first on an elaboration of the diagnostic criteria for GAD, and second on a comparison of 
those criteria with the defining symptom clusters for the remaining anxiety subgroups listed 
in the current version of the DSM. 
 In broad terms, people affected by GAD report feeling extreme worry about life in its 
entirety. This worry, which might have initially occurred in response to a particular life event, 
generalises to numerous other situations that cause the person to feel intense anxiety with 
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minimal capacity to identify or explain any reasons for that anxiety (NIMH, 2010). The 
DSM-IV-TR (APA, 2000) presents six diagnostic criteria (A - F) to assist clinicians in the 
accurate identification of GAD (see Appendix A for GAD diagnostic criteria). Criterion A 
refers to specific symptoms (i.e., excessive worry and anxiety) plus temporal (i.e., presence 
of symptoms for greater than six months) and severity (i.e., symptoms associated with a 
number of life events) guidelines. Criterion B specifies that the reported worry will be outside 
of the person‘s control. Criterion C presents six mostly somatic symptoms with the 
requirement that the person show evidence of three symptoms for more days than not during 
six months prior to diagnosis. Criterion D serves the purpose of emphasising that the worry 
and anxiety that are indicative of GAD must not be limited to the features of another Axis 1 
Disorder. This criterion also lists eight such features plus the Axis 1 disorders those features 
derive from (i.e., Panic Disorder, Social Phobia, Obsessive Compulsive Disorder, Separation 
Anxiety Disorder, Anorexia Nervosa, Somatisation Disorder, Hypochondriasis, and Post-
Traumatic Stress Disorder). Criterion E focuses on the negative impacts of GAD on 
functioning by making reference to anxiety symptoms that cause clinically significant 
impairment in social, occupational and other areas of day-to-day performance. Criterion F 
centres on differentiation between GAD and other physiological effects (e.g., medication), 
medical conditions (e.g., hyperthyroidism), and mental conditions (e.g., Psychotic Disorder) 
which might result in similar clinical presentation to GAD. 
 Accurate identification of mental disorder requires not only distinction between the 
target disorder and other diagnostic groups (e.g., GAD versus Psychotic Disorder) but also 
delineation between the target disorder and subgroups which fall within the same broad 
classification (e.g., GAD versus Social Phobia). Clarity on the ways in which the various 
anxiety subgroups differ is central not only to accurate diagnosis but also for determinations 
on the most appropriate therapeutic approaches. In light of this, the subsequent discussion 
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will examine the ways in which GAD differs from the codable anxiety disorders contained in 
the DSM-IV-TR (APA, 2000). It should be noted that the purpose of this discussion is to 
identify the key bases on which each codable anxiety disorder differs from GAD rather than 
in-depth presentation of diagnostic criteria and symptom manifestation (see Appendix B for 
summary of features for Anxiety Disorder as per DSM-IV-TR [2000] Diagnostic criteria). 
 Panic Disorder is characterised by the presence of repeated and unanticipated panic 
attacks plus intense concern (of at least one month in duration) about the possibility of 
another attack occurring, and the implications of losing control. Panic Disorder can present 
with or without Agoraphobia in which anxiety relates to being in situations where the 
avenues for escape or access to help, following an attack, are low (DSM-IV-TR [APA, 
2000]). Differentiation between GAD and Panic Disorder centres on the absence of panic 
attacks in the former but, as with all anxiety disorders, substance use/abuse and medical 
conditions must be excluded as being the causes for panic attacks (DSM-IV-TR [APA, 
2000]).  
 The defining feature of Specific Phobia is an intense and irrational fear arising from a 
particular object or situation which does not contain fear-inducing qualities. The reference to 
irrationality emphasises that the experience of fear is generally unjustified and, despite 
possible awareness that the fear-causing stimulus is indeed neutral and the fear-response is 
exaggerated, avoidance of that stimulus persists, causing disruption in day-to-day functioning 
(DSM-IV-TR [APA, 2000]). GAD can be distinguished from Specific Phobia because the 
symptoms of worry and anxiety in GAD are not linked to one specific event but generalised 
across multiple situations. Social Phobia is present when the person experiences severe and 
persistent fear in relation to one or more social or performance events which contain 
unfamiliar people or the potential for the person to be adversely judged by others. As is the 
case with Specific Phobia, a common behavioural outcome of Social Phobia is active 
9 
 
 
 
avoidance of and/or escape from the feared social event. Although GAD might include worry 
and anxiety arising from social events, these adverse states are associated with a broader 
range of situations and avoidance is not always the likeliest response (DSM-IV-TR [APA, 
2000]).  
 Obsessive-Compulsive Disorder (OCD) features recurrent preoccupations (i.e., 
thoughts, impulses or images) and/or compulsive behaviour patterns accompanied by 
recognition that obsessions/compulsions are excessive. The time spent engaging in 
obsessions/compulsions and the disruption caused in day-to-day functioning result in 
substantial distress. GAD is not associated with intense fixations or repetitive behaviour 
patterns and this is the basis for differentiation from OCD (DSM-IV-TR [APA, 2000]). Post-
Traumatic Stress Disorder is described as resulting from exposure to an identifiable extreme 
traumatic event. Key symptoms include re-experiencing (via thoughts and dreams) the event, 
persistent avoidance of antecedents associated with the event, and increased autonomic 
arousal when such antecedents are present. GAD does not involve prior exposure to a 
traumatic stressor nor does it prompt intense reactivity to, and avoidance of, antecedents in 
the environment (DSM-IV-TR [APA, 2000]). Acute Stress Disorder also results from 
exposure to a traumatic event and, in this instance, the person experiences a dissociative 
symptom such as depersonalisation or subjective sense of numbing either during or after the 
event occurs. The differentiation between Acute Stress Disorder and GAD is based on the 
absence of a traumatic event and dissociative symptomatology. GAD symptoms are also not 
associated with presence of a specified medical condition and this is the primary basis for 
differentiating GAD from Anxiety Disorder due to a Medical Condition. Similarly, GAD 
does not arise from the intake of an identifiable substance or medication, which is the case for 
Substance-Induced Anxiety Disorder. 
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2.2  Conceptualisations of Anxiety 
 Explicitly stated diagnostic criteria for mental disorders facilitate identification, inter-
disciplinary communication on client status, and decision-making regarding appropriate 
treatment. In particular, description of symptoms and the ways in which those symptoms 
cause disruption in day-to-day functioning enhances clinicians‘ understanding of clients‘ 
experiences and the challenges they face as a result of suffering from anxiety. However, and 
despite clearly articulated DSM diagnostic guidelines, the manner in which anxiety and its 
causes is conceptualised varies in relation to the theoretical perspective taken by researchers 
and clinicians in the field (Neef & Iwata, 1994; Jones & Friman, 1999). Therefore, a review 
of the major theoretical perspectives on anxiety will assist in establishing a clear basis for 
determining how anxiety is understood by those who treat it in their clinical practice. 
 2.2.1 Psychological Conceptualisation of Anxiety 
 Psychological descriptions of anxiety generally adhere to two themes: first, 
identifying symptom profiles to aid accurate diagnosis, and second, determining the capacity 
of those symptom profiles to cause significant disturbance in day-to-day social and 
occupational functioning. Therefore, DSM diagnostic criteria have been elaborated into 
specific covert (e.g., elevated heart rate and subjective unease) and overt (e.g., verbalised 
worrying and fidgeting) responses which, when present with sufficient intensity, indicate 
functional disturbance due to anxiety (Barlow & Durand, 2005). The decision regarding level 
of anxiety and associated disturbance to functioning is often based on norm-based 
comparisons or at the least clinician‘s impression of behaviour which extends outside of the 
expected norm for stage of life (Bitsika, 2006). Psychologically-oriented definitions for 
anxiety are sometimes criticised due to their focus on only a limited range of the anxious 
person‘s experiences. For instance, the Caltabiano and Sarafino (p. 95, 2008) definition 
which states that “.... anxiety is a vague feeling of unease or apprehension, a gloomy 
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anticipation of impending doom that often involves a relatively uncertain or unspecific 
threat ....” represents only the cognitive and emotional aspects of the anxiety experience. 
Similarly, restricting conceptualisations of anxiety to particular erroneous cognitive processes 
as is seen in the Good and Beitman (2000) hypothesis on the cause for anxiety 
                       
                                  
                                   
   which suggests that anxiety 
results from cognitive appraisals which overestimate the level of situational threat plus 
underestimate the available resources to cope with that threat, do not allow for inclusive 
explanations regarding individuals‘ experiences. 
 2.2.2 Medical Conceptualisation of Anxiety 
 The medical model of fear and anxiety originated from the evolutionary or primordial 
“fight or flight” mechanism and is focused on the more primitive areas of the brain leading to 
it being conceptualised as a direct physical process (Marks & Nesse, 1994). Physiological 
descriptions of anxiety are considered to emphasize and explain the somatic symptoms and 
underlying neurological pathways associated with onset of those symptoms. Hoehn-Saric and 
McLeod (2000) defined anxiety as a biological warning system that activates the sympathetic 
part of the autonomic nervous system via a neuroendocrine response (by activation and an 
escalation of epinephrine, norepinephrine, cortisol, growth hormone and prolactin). 
Activation of the sympathetic nervous system causes physiological hyperarousal (i.e., surge 
in heart rate, blood pressure, sweat gland activity, respiration and increased in gastro 
intestinal and bladder activity). More recent studies using neuroimaging and 
neuroendocrinological methods have illustrated the complexity of the anxiety response in 
humans with the interaction of cognitive processing of a stressful event and the activation of 
the biological fear responses (Hofmann & Dibartolo, 2010; Shin & Liberzon, 2010; Porto et 
al., 2005).  
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 Therefore, from this theoretical perspective, anxiety is viewed primarily as a 
physiological disorder characterised by tension and overactivity of the autonomic nervous 
system (ANS). Further, it is the escalation in ANS activity which is at the basis of the 
cognitive (e.g., apprehension), emotional (e.g., worry), and behavioural (e.g., hyper-vigilance) 
symptoms used in psychological models for assessment to identify whether anxiety is present 
(Carlson, 2013; Sherwood, 2010; Tortora & Grabowski, 2000). As with psychological 
descriptions of anxiety, medical conceptualisations of this disorder have been appraised as 
being limited due to their focus on somatic symptomatology and neurological antecedents. 
The conceptualisation of anxiety as an adverse somatic experience which leads to emotional 
distress and behavioural disturbance will be elaborated in Chapter 4 of this thesis where the 
focus will be on employing physiological monitoring and biofeedback to measure and 
remediate anxiety. 
 2.2.3 Functional Analytic Conceptualisation of Anxiety  
 Functional Analytic Models for anxiety have received increasing attention in the 
clinical field due to their inclusion of all symptom modalities (i.e., somatic, cognitive, 
emotion, and behaviour) and their capacity to incorporate the relative impact of antecedents 
on the onset and development of this disorder (Miller, 1997; Barlow, 2002; Bitsika, 2005). 
These models are based on idiographic assessment methods characterised by collection of 
data samples which first, allow for individualised descriptions of symptoms and responses 
and then identify the antecedents which are most likely to cause escalation in anxiety and any 
associated deterioration in coping (Barlow, 2002; Friman, 2006). The association between 
antecedent factors and anxiety-based behaviours traditionally referred to as the stimulus-
response link by Mowrer (1939) and Skinner (1953) is central to functional analytic 
explanations for persistent anxiety and has led to chain-of-events conceptualisations of this 
disorder. One such simplified chain-of-events might begin with a stimulus (e.g., spider) or 
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stimulus situation (e.g., public speaking) which is known to cause fear. The chain is initiated 
when the stimulus/stimulus situation is present, causing the onset of unpleasant somatic 
responses (arising from ANS arousal) and adverse cognitive/emotional responses, and 
leading the individual to engage in some form of escape or avoidance behaviour as the 
mechanism for reducing the elevated discomfort (i.e., the anxiety) being experienced (Barlow, 
2002; Friman, 2006; Miltenberger, 2004). The Functional analytic model, with specific 
reference to its capacity for person-centred assessment of the contextual causes of anxiety, is 
submitted to in-depth examination in Chapter 3 of this thesis. 
 This thesis will apply the physiological and Functional Analytic Models for 
conceptualising GAD in order to gain an in-depth understanding of the disorder itself as well 
as the environmental variables which might be associated with its occurrence. Criterion C of 
the DSM-IV-TR (APA, 2000) specifies that the worry and anxiety which feature in GAD are 
associated with three of six symptoms: feeling restless or feeling keyed up or on the edge 
(somatic), being easily fatigued (somatic), having difficulty concentrating or mind going 
blank (cognitive), irritability (somatic), muscle tension (somatic), and sleep disturbances 
(somatic). Review of this symptom list indicates that the vast majority of indicators for GAD 
are somatic in nature, thus providing a basis for assessing anxiety in relation to its 
physiological manifestations. Additionally, research suggests (DSM-IV-TR [APA, 2000], 
Barlow & Durand, 2005; Sturmey, 2007) that the symptoms of GAD, whilst clearly linked to 
disordered functioning, can be more clearly defined when conceptualised as specific units of 
overt and covert behaviour and better understood as adaptive responses when linked to those 
variables which are responsible for the exacerbation of those symptoms. The Functional 
Analytic Model provides a sound basis for examining how particular situations in day-to-day 
life contribute to experiences of anxiety. 
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CHAPTER 3 
Functional Assessment of Anxiety 
 Behaviourally-oriented methods which allow for individualised assessment of the 
day-to-day difficulties associated with mental illness are increasing in popularity in the 
Counselling field (Burns, Hoagwood & Mrazek, 1999). The intent and focus of these 
behavioural methods are best understood via comparison with traditional approaches to 
assessment. Traditional, or nomothetic, assessment processes centre on administration of 
standardised tests to determine the presence and severity of symptom clusters that are 
indicative of mental disorder. Review of client symptoms with an externally-derived standard, 
such as the diagnostic criteria of the DSM, becomes the basis for identifying whether a 
mental disorder exists (Bitsika, 2003). Nomothetic assessments are particularly suited to 
accurate diagnosis and, when applied to therapy, provide a label (e.g., Generalised Anxiety 
Disorder) which guides delivery of ―manualised‖ treatments designed to reduce symptom 
severity. However, nomothetic approaches, whilst providing a robust foundation for accurate 
diagnosis, have received criticism as treatments because they do not adequately account for 
the variation in the experiences and life circumstances which exist between people with the 
same diagnosis.  
 In contrast, idiographic approaches collect in-depth information on the specific 
behaviours which arise from mental disorder and the range of variables which appear to be 
linked to occurrences of those behaviours (Sugai et. al., 1999). Of significance to this 
approach is examination of the ways in which behaviours assist the person to cope with 
demand in their day-to-day lives. This idea that the same behaviour (or symptom) which 
indicates the presence of a mental disorder can also become a coping method is central to 
understanding each person‘s particular experiences. Therefore, idiographic treatment 
approaches, instead of focusing on symptom reduction, are designed to build positive coping 
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skills capable of generalising to the full range of situations which cause the person distress 
(Bitsika, 2005). Functional Assessment is an idiographic framework which has been 
submitted to extensive investigation and offers a validated basis for assessing and treating 
people with mental disorder. The discussion which follows describes Functional Assessment 
procedures and elaborates on the application of these to examination of GAD. 
3.1. Evolution and Applications of Functional Assessment 
 The idea that ―problem‖ behaviour might become purposeful over time was first 
introduced by B. F. Skinner (1953), who argued that behaviour did not occur in isolation but 
in response to particular external (in the environment) or ‗inner skin‘ (within the person) 
variables. He is credited with introducing systematic processes for observation, recording, 
and analysis of the variables thought to encourage instances of problem behaviour (i.e., 
maintaining variables). The experimental work done by Bijou, Peterson and Ault (1968) 
focused on application of observational and data-recording techniques to highly challenging 
behaviour as it occurred in the natural environment. Their aim was to establish procedures for 
identifying the functions of challenging behaviour via examination of how it varied in the 
presence of particular antecedent and consequent variables in the environment. The research 
of Bijou, Peterson and Ault (1968) which centred on people with developmental disabilities, 
was crucial to shifting the assessment focus from labelling behaviour to understanding its 
causes and establishing the procedures which underpin Functional Assessment of behaviour. 
 Initial applications of Functional Assessment were limited to people with severe 
behavioural challenges and minimal communication skills often associated with an 
intellectual or developmental disability. These groups were often excluded from educational 
and other opportunities due to their highly aberrant behaviour and Functional Assessment 
provided one basis for understanding their needs and assisting them to learn alternative 
methods for interacting with their environment (Carr & Durand, 1985; Iwata et al, 1994). 
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 Since its initial applications, Functional Assessment procedures have been sufficiently 
elaborated to allow for investigation of numerous client groups. Clinical researchers such as 
Miltenberger (2004) argued that, despite commonalities in the data-collection and data-
interpretation procedures which characterise Functional Assessment, there now exist a range 
of frameworks which have been developed to tailored investigation of particular groups, 
contexts, and presenting problems. Sturmey (2007) described four models for Functional 
Assessment and these are briefly discussed below to demonstrate the range of investigations 
into behaviour-environment relationships which are possible. 
 Functional Assessment of individual cases is generally applied to understanding 
the purpose of problem behaviour which is highly aberrant, disruptive to functioning, and 
appears to be unpredictable to the observer. Due to these features, the behaviour is submitted 
to in-depth and multi-method investigation to maximise the chances of identifying covert 
antecedents and subtle and/or idiosyncratic reinforcers. Examples of this type of Functional 
Assessment include investigation into suicidal threats (Sturmey, 1995) hallucinations (Layng 
& Andronis, 1984), and self-injury (Iwata & Neef, 1994). Functional Assessment of a 
process has been applied to examining skill deficits or atypical responses in children with 
developmental disabilities and the focus is on tracking how development of a particular skill 
set (e.g., verbal communication) occurs in a normally-developed sample. These data are used 
to build a template for establishing the pre-requisite skills necessary for the process to occur 
effectively. Data on the ways in which the process occurs in individual children are compared 
against this template to identify any missing pre-requisite skills and adverse environmental 
factors which might interfere with effective development of the target process. Examples of 
this type of Functional Assessment include investigations into imitation (McCuller & 
Salzberg, 1982) and communication (Koegel, 2000). Ecological Functional Assessment refers 
to a data-collection and interpretation process designed to identify the maintaining variables 
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which might impact the behaviour of a group of people participating in the same system or 
ecology. Data-collection focuses on identifying multiple behaviour-environment interactions 
to describe how the system impacts on members of the group. Examples of this type of 
functional assessment include examination of how social reinforcement influences student 
behaviour in the classroom and identification of the variables thought to inhibit completion of 
academic tasks (Bitsika, 2008). 
 Of great significance to this thesis is the Functional Assessment of a diagnostic 
category in which a DSM diagnosis (e.g., Generalised Anxiety Disorder) or cluster of 
symptoms (e.g., anxiety escalation) that are possibly indicative of the presence of a mental 
disorder, become the focal point for the investigation. The majority of research has dealt with 
diagnostic categories which have been operationalized and investigated in relation to their 
specific behaviours (symptoms), plus the relationships between those specific behaviours and 
particular environmental variables (e.g., presence of anxiety-provoking stimulus) and inner-
skin experiences (e.g., negative self-talk) (Bitsika & Sharpley, 2006). Data are analysed to 
identify significant antecedent-behaviour and behaviour-consequence links to assist in 
understanding how problem behaviour might be functional as well as problematic. This type 
of Functional Assessment has applied learning theory to understand firstly how disorder 
develops and secondly how it persists over time; examples include investigations into the 
onset of Anorexia Nervosa (Slade, 1982), school refusal (Kearney & Silverman, 1990), and 
depression (Dougher & Hackbert, 1994).  
 Contemporary definitions of Functional Assessment emphasise that this is not a 
standard process but instead a flexible set of procedures which are applied to identify the 
causes of problem behaviour (Cooper, Heron & Heward, 2007). Despite the advances in 
generating tailored methods for conducting investigations, the core features of Functional 
Assessment continue to include observation, data recording, and data interpretation (O‘Neill 
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et al., 1997). There is also consistency in the targets for data-collection (i.e., antecedents-
behaviour-consequences) and these will be defined and explained in the subsequent 
discussion. 
3.2. Contemporary Functional Assessment Procedures 
 Various researchers (e.g., Cooper, Heron & Heward, 2007; Miltenberger, 2004; 
O‘Neill et al, 1997) have proposed that a comprehensive Functional Assessment should 
involve the clinician in collecting data on three factors: behaviour of concern (i.e., target 
behaviour), pre-behaviour events thought to encourage occurrences of the behaviour (i.e., 
setting events, antecedents), and post-behaviour events considered to strengthen behaviour 
(i.e., consequences, functions). These data are examined to develop hypotheses as to the 
reasons why behaviour occurs; those hypotheses are then employed to assist people in 
learning alternative strategies for responding to demand. 
 The Functional Assessment process begins with an operationalised definition of the 
behaviour which is causing the person concern and disruption in his/her capacity for effective 
functioning. This definition, which provides clarity on the specific aspect of performance to 
be assessed, is broadly considered in relation to whether it is external and observable (i.e., 
overt behaviour) or internal or not able to be observed (i.e., covert behaviour). In addition to 
this, the definition must account for the topography of the behaviour by identifying whether it 
is an action, verbalisation, cognition, emotion, and/or physiological state (Miller, 1997). Carr 
(2000) argued that data-collection on ill-defined behaviour will not only lead to partial or 
misleading measurement of that behaviour but also erroneous identification of maintaining 
variables. In addition to developing an operationalised definition, the clinician is required to 
decide on the dimensions to be used in measuring instances of the target behaviour in the 
natural context. Target behaviour might be measured in relation to one or more of four 
dimensions including: frequency (i.e., number of occurrences of behaviour per unit time), 
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duration (i.e., length of time for which one instance of behaviour lasts), intensity (i.e., 
magnitude of effort or resources involved in exhibiting the behaviour), and latency (i.e., time 
period between presence of specific trigger event and onset of behaviour) (Miller, 1997). 
Cone (1997), and Crone and Horner (2000) have recommended that clinicians be 
parsimonious in their inclusion of measurement methods by limiting the number of 
dimensions they employ to investigate behaviour. Interestingly, contemporary Functional 
Assessments, especially those which investigate DSM diagnostic categories, incorporate 
global measures of the mental disorder as well as precise measures of target behaviours. For 
instance, depression might be measured in relation to severity of depressive mood as well as 
specific behaviours such as crying and negative self-statements. Similarly, GAD might be 
best investigated via measures of general anxiety plus focus on specific avoidant behaviours 
(Bitsika & Sharpley, 2006). 
 The Functional Assessment also collects information on those events or conditions 
which precede the behaviour and appear to encourage its occurrence. Those pre-behaviour 
events are described in relation to their temporal relationship to the behaviour. The term 
setting events refers to a range of factors which have either occurred well before the 
behaviour (e.g., migraine several days before escalation in anxiety) or represent a general 
aspect of the environment in which the behaviour occurs (e.g., high demand at work leading 
to intense feelings of self-doubt) (Bitsika, 2007). Sturmey (2007) has cautioned that, in cases 
where behaviour appears not to be associated with any identifiable event in the immediate 
environment, it is probable that it is under the control of setting events. This appears to be 
particularly relevant to behaviour patterns which are generalised in nature (e.g., GAD, PTSD) 
and research has increasingly focused on identification of classes of setting events that might 
be significant to different types of mental disorder as opposed to specific behaviours. In 
contrast to setting events, antecedents are more readily recorded as they immediately precede 
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the behaviour of concern. However, because behaviour is often under the influence of 
multiple antecedents, it is important to group related types of antecedents to facilitate data 
analysis and decisions regarding treatments involving antecedent manipulation strategies 
(Miltenberger, 2004). Bitsika (2007) recommended that antecedent events might be grouped 
according to whether they are task-based (e.g., reading a challenging email), object-based 
(e.g., diary), or interaction-based (e.g., speaking with a supervisor). Basic antecedent 
grouping methods such as this not only highlight any antecedent types that are significant to 
occurrences of the behaviour but also provide a sound basis for educating the person about 
the activities which potentially cause distress. 
 The primary goal of Functional Assessment is to identify those events which follow 
instances of the behaviour and cause it to be strengthened over time. It is believed that 
behaviour which continues to occur, often despite causing discomfort to the person who 
exhibits it, does so because it is purposeful and adaptive. Assessment of post-behaviour 
events requires the clinician to describe the reinforcement processes which strengthen 
behaviour and the functions which give it adaptive value. Sturmey, 2007 stated that four 
reinforcement processes should be reviewed to understand the mechanisms by which 
behaviour is strengthened: (i) social positive reinforcement, (ii) social negative reinforcement, 
(iii) automatic positive reinforcement, and (iv) automatic negative reinforcement. Social 
reinforcement is considered to occur when the behaviour reliably leads to some change in the 
social environment which is meaningful to the person. Social positive reinforcement involves 
the onset of a liked or valued social event (e.g., recognition, sympathy) and social negative 
reinforcement results in removal of a disliked or aversive social event (e.g., conflictual 
interaction, stressful work meeting) (Birchler, Weiss & Vincent, 1975). Automatic 
reinforcement occurs when the behaviour creates some form of internal change that is not 
influenced by any aspect of the social environment. This form of reinforcement is closely 
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linked to the concept of private events which is used to refer internal or ‗within skin‘ factors 
which influence behaviour but cannot be detected by an observer. Automatic positive 
reinforcement involves the onset of a liked and valued internal change (e.g., satisfaction, 
pleasure), and automatic negative reinforcement occurs when an adverse internal state ceases 
(e.g., anxiety, sadness) (Bitsika & Sharpley, 2006). Mineka and Oehlberg (2008) proposed 
that clinicians should review consequent events in relation to all four reinforcement processes 
but also caution that, in the case of automatic reinforcement, identification depends on self-
reports from the person regarding any changes in internal state following behaviour. 
 Behaviour-consequence data are also analysed to determine the purpose (or functions) 
of the behaviour in order to determine how the behaviour interacts with the environment to 
produce a desired outcome. Numerous studies (e.g., Dunlap et al., 1993; Horner, Sugai, Todd 
& Lewis-Palmer, 2000; O‘Neill et al, 1997) have shown that problem behaviour is capable of 
serving one or more functions such as escape, avoidance, attention, access to a preferred 
activity/object, and sensory reinforcement. Recent research suggests that the behaviours (or 
symptoms) associated with mental disorders serve a number of functions and these must all 
be identified in the Functional Assessment process. 
3.3. Functional Assessment Procedures for Anxiety 
 Dymond and Roche (2009) argued that high-incidence disorders such as anxiety are 
rarely submitted to idiographic investigation, and discuss two issues which have possibly 
contributed to the reluctance of behavioural researchers to advance Functional Assessment 
models specific to anxiety. The first issue relates to difficulties in generating operationalised 
and precise definitions for anxiety. The second issue centres on misinterpretation of the 
concept of ‗private events‘ or ‗inner skin‘ variables by radical behaviourists. 
 Sturmey (2007) pointed out that there are 12 anxiety subtypes (or diagnoses) listed in 
the DSM-IV-TR (APA, 2000) which contain symptom clusters described primarily on the 
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basis of the intensity and duration of symptoms with no clear definition of the anxiety 
disorder which produces those symptoms. Barlow (2002) proposed a remedy to this 
definitional problem by suggesting that anxiety be conceptualised as a fear response which 
involves awareness and thoughts of constant danger, an increase in autonomic nervous 
system arousal, plus onset of overt and covert behaviours to ensure avoidance and escape. 
This reference to fear response acknowledges that stimuli which evoke fear-like reactions are 
often generic in nature, anticipated but not actually present, and pose no danger to the 
person‘s well-being (Barlow, 2002; Sturmey, 2007). This is in contrast with authentic fear 
which is generated in relation to specific, imminent, and hazardous events. Further 
complication to development of operational definitions of anxiety arises from clinical 
accounts which focus on ‗inner skin‘ symptoms such as worry, nervousness and irritability 
rather than overt responses, which in radical behaviourism terms do not offer a sufficient 
basis for observation and accurate measurement of behaviour (Anderson, Hawkins & Scotti, 
1997).  
 However, more recently, researchers have emphasised that even Skinner (1975) 
explicitly recognised the existence of private events in the treatment of anxiety and have 
argued persuasively for inclusion of those events in the assessment of anxiety disorder 
(Friman, Hayes & Wilson, 1998; Mineka & Zinbarg, 2006). Friman, Hayes and Wilson 
(1998) suggested that ‗inner skin‘ events should be incorporated in behaviour analytic 
conceptualisations of anxiety disorders and argued strongly for inclusion of emotions as 
targets for investigation in the assessment process. Those researchers proposed that language-
proficient humans are capable of forming connections between neutral stimuli and their 
responses with no direct training. Humans are also capable of communicating with clinicians 
about those connections to enhance understanding of their personal experiences of anxiety 
and the stimuli which cause it. Further, the distinguishing feature of anxiety disorders is their 
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occurrence as a result of derived rather direct relations between overt and private responses 
aimed at serving avoidant functions. Thus, those researchers recommended that anxiety is 
suited to Functional Assessment investigation.  
 Researchers (e.g., Dougher & Hackbert, 2000; Lovibond, Saunders, Weidemann, & 
Mitchell, 2008; Bronfenbrenner & Morris, 2006; Sturmey, 2007) worked towards the 
development of four general guidelines for idiographic assessment of anxiety. The first 
guideline suggests that private events, as they relate to possible explanations for antecedents, 
target behaviours, functions and reinforcement processes, should be included in the 
assessment of anxiety. The second guideline suggests that, since fear responses relate to 
generic and often anticipated stimuli, particular attention should be given to the investigation 
of setting events as variables which set the conditions for anxiety. The third guideline derives 
from research (e.g., Dymond and Roche, 2009) argues that there is a close connection 
between the fear response and avoidant behaviour and requires in-depth investigation of the 
mechanisms for avoidance in order to understand how it facilities reduction in anxiety. The 
fourth guideline relates to the operant research (e.g., Miltenberger, 2004; Skinner, 1975) 
which suggests that avoidance results in negative reinforcement and suggests that 
determination of reinforcement processes must centre on social negative as well as automatic 
negative reinforcement. Interestingly, Woods, Miltenberger and Carr (2006) alerted the 
clinician to a two-step reinforcement process which applies in the case of fear-based 
behaviour and is distinguished in temporal terms and reinforcement type. Those researchers 
suggested that the immediate consequence to fear responses results in automatic negative 
reinforcement as evidenced by feelings of relief and deceleration of physiological arousal 
when avoidance succeeds. (This process is referred to as primary reinforcement.) However, 
once separation from fear-evoking stimuli is secured, it is argued that the person will 
generally engage in an activity which produces social and/or automatic positive 
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reinforcement. (This process is referred to as secondary gain.) A practical illustration of this 
two-step reinforcement process might involve a person experiencing a fear response (e.g., 
increased heart rate, trembling, and feelings of panic) triggered by a fear-inducing stimulus 
(e.g., imminent dentist appointment) leading to cancellation of the appointment and feelings 
of relief (i.e., automatic negative reinforcement as the primary reinforcement process) and 
initiation of contact with a friend to discuss the fear responses (i.e., social positive 
reinforcement as the secondary gain). 
3.4 Proposed Functional Assessment Framework for GAD 
 The current study employed Functional Assessment of GAD as the method for 
establishing an in-depth understanding of fear-based behaviour and identifying the key 
maintaining variables for that behaviour. The Functional Assessment Model applied in this 
study reflected the traditional data-collection and data-interpretation procedures for best-
practice investigation into problem behaviour as well as the guidelines which refer 
specifically to investigation of anxiety. It was considered to reflect the key components 
necessary to conduct an idiographic assessment of a diagnostic group but, due to a paucity of 
research specifically dedicated to Anxiety Disorders, the intention was to apply this model in 
a trial manner and then to evaluate its capacity to provide meaningful data in relation to 
participant anxiety-based experiences as these occurred in day-to-day life (refer below for 
Functional Assessment data-recording steps employed in this study): 
1. Define the fear response in relation to overt behaviour and ‗inner skin‘ responses; 
2. Measure fear response in relation to frequency, duration, intensity, and latency; 
3. Identify key setting events and antecedents for the fear response; 
4. Decide whether post-behaviour consequences result in positive reinforcement or 
negative reinforcement (social and/or automatic); 
5. Identify the functions of the fear response. 
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3.5 Functional Assessment Data-Collection and Data-Analysis Methods 
 O‘Neill, Horner, Albin, Sprague, Story and Newton (1997) stated that the Functional 
Assessment process is embedded in the use of observational and data-recording procedures 
designed to investigate a presenting problem and determine the range of antecedent and 
consequent events that contribute to and maintain that problem over time. Specific data-
recording procedures can include standardized tests of ability, self-report scales, interviews, 
and direct observations in natural and/or simulated environments (O‘Neill, 1997). Selection 
of data-recording procedures is undertaken in relation to factors such as client features (e.g., 
age, ability level, communication skills), presenting problem topography (e.g., self-injurious 
behaviour versus generalised feelings of worry and nervousness), treatment applications (e.g., 
one-to-one Counselling therapy, parent training, classroom intervention). Factors such as 
these are important in determining the strategies for data-recording and it falls to the clinician 
to design an individualised data-recording process tailored to the particular needs of 
individual clients and their presenting problems.  
 Kohlenberg and Tsai (1991), in their application of Functional Assessment principles, 
design of assessment and psychotherapeutic approaches suited to the Counselling context, 
recommended that data-recoding should be undertaken within a client-therapist relationship 
based on strong rapport, trust, and empathy. Further, it is suggested by those researchers that 
interviewing comprise the major strategy for data-recording because Counselling clients are 
capable of communication, self-reflection, and self-observation. The importance of 
interviewing as a data-recording process is supported by Hanely (2012), who argued that 
‗open‘ assessment methods such as semi-structured interviews hold most promise for gaining 
in-depth and client-relevant data regarding problem behaviour and its probable causes. 
Because the research (Carr, 1994, 2000; Sturmey, 1996) has clearly demonstrated that 
Functional Assessment requires a multi-source investigation of problem behaviour, 
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interviews are commonly paired with other data-recoding methods such as rating scales and 
direct observation. These methods are particularly suited to assessment of diagnostic 
categories and can provide a basis for reviewing key trends across data sources so as to 
ensure that any conclusions on client anxiety symptomatology are accurate.  
 Multi-source data are submitted to in-depth analysis and review in order for the 
clinician to understand the presenting problem (i.e., target behaviour, topography, and 
dimensions) and it‘s maintaining variables (i.e., setting events, antecedents, functions). Most 
importantly, those data are used to generate a number of hypotheses regarding the purpose of 
target behaviour to further understand how particular behaviour which causes client distress 
might also be assisting him/her to adapt to and cope with demand. These hypotheses are 
thought to enhance the psychotherapeutic process by assisting the client to understand the 
adaptive aspects of their ‗problem‘ and to form the foundation for individualised treatments 
aimed at creating client-focused (e.g., building coping behaviours to compete with and 
eventually replace concerning behaviours) and environment-focused changes (e.g., modifying 
antecedents shown to trigger use of concerning behaviours) (Kohlenberg & Tsai, 1991; 
Sturmey, 1996).  
 There is some confusion in the literature about the distinction between Functional 
Assessment and Functional Analysis, with these terms being used interchangeably in various 
studies. Mace (1994) and O‘Neill et al. (1997) sought to clarify this confusion by proposing 
that a Functional Analysis of behaviour involves all the data-recording and data-interpretation 
procedures central to a Functional Assessment, plus the inclusion of a final process described 
as a systematic manipulation of consequent variables following instances of target behaviour 
in order to confirm the veracity of hypotheses in explaining the purpose of that behaviour. 
This confirmation, which required formal experimentation often conducted in a laboratory to 
minimize contamination of consequent variables, was historically devised for people with 
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developmental disabilities and is not suited to idiographic investigations of regularly-
functioning adults. 
 This thesis was concerned with idiographic assessment of a group of adult participants 
with a diagnosed mental disorder (i.e., GAD) and applied multi-source assessment via semi-
structured interviews and standardized anxiety scales within the context of the client-therapist 
relationship. Assessment data were submitted to an in-depth review to understand the 
particular ways in which GAD manifested itself and the impacts of that condition on the day-
to-day functioning of the participant group. The results of the Functional Assessment for 
GAD are discussed in Chapter 6 of this thesis. 
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CHAPTER 4 
What is Biofeedback? 
 Basmajian (1979) defined biofeedback (BFB) as a process whereby an organism (in 
this case, humans, although the biofeedback process is not restricted to human usage) can 
learn to modify physiological events in the body when these are displayed on a recording 
device, either as visual and/or auditory signals. That is, BFB is based upon learning principles 
of (i) exhibition of a specific physiological aspect of behaviour (e.g., heart rate) on some 
modality or replicate such as a pc screen, audio device, or other combination of audio and 
visual stimuli that accurately depict the physiological behaviour  under scrutiny in a time-
dependent manner so that moment-to-moment variations in the physiological  behaviour are 
reflected in the audio-visual (A/V) depiction, (ii) awareness of that depiction by the person 
whose physiological function is being measured and depicted, and (iii) graduated self-control 
learning that enables the person to reliably alter their physiological function at will. 
 That is, the first stage of BFB requires that the person provides access to their 
particular physiological behaviour that is chosen for examination. While perhaps obvious, 
this stage is vital in terms of the overall process of BFB. Without voluntary provision of 
access to the measurement devices required to measure the physiological behaviour under 
scrutiny, the second and third stages are unlikely to follow. Therefore, as well as being a 
significant ethical issue in research and clinical treatment, voluntary access to the person‘s 
physiology is a requirement of BFB and thus ensures that there is no uncertainty about the 
person‘s ‗buy-in‘ to the therapy and to their engagement in the therapy process via the 
Therapeutic Alliance. This is an important step in ensuring that, in clinical settings such as 
those described in this thesis; the client is an informed and willing part of the overall therapy 
process. 
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 The second stage of BFB is open to some development and variation according to the 
sophistication (and budget) of the therapist or researcher. As will be described later in the 
Methods chapter, the equipment used in this thesis represented the most non-invasive 
available at the time of the research and so minimised the (perhaps daunting for some clients) 
challenge of being attached to electronic equipment. As will be described later, the BFB 
equipment used in this thesis presented a visual and auditory signal for clients to see and hear. 
 The third stage of BFB relies upon operant principles of learning in that the person 
undergoing BFB  is aware of the A/V depiction of their physiological behaviour  and then 
gradually also becomes aware that the signal (i.e., the A/V depiction) varies from time to time. 
This vital third step in BFB allows the person to experiment with other physiological 
behaviours that may influence the behaviour being depicted. In the present thesis, the 
behaviour being depicted is heart rate (HR) and this naturally varies with breathing as a 
function of the respiratory-sinus-arrhythmia changes which bring HR under the control of the 
Sympathetic Nervous System (SNS) when the person inhales and then under the control of 
the Parasympathetic Nervous System (PNS) when the person exhales. This SNS-PNS 
exchange over breathing cycles produces a gradual increase and decrease of HR during those 
breathing cycles. When training people to use HR BFB, it is awareness of this SNS-PNS 
variability in HR which is the first aspect of their learning. That is quickly followed by 
experimentation by the person receiving BFB so that they vary their breathing cycle (e.g., 
extend the exhale period) to see what effects this has upon the HR. Thus, the person is then 
effectively in control of some aspects of their HR and has achieved this by the BFB process. 
 Thus, the definition of BFB by Hayashino et.al, 2010 as a method helping individuals 
learn how to control various physiological processes such as muscle tension, blood pressure, 
breathing, heart rate, brainwave states, skin temperature and skin conductance measured by 
non-invasive sensors and providing visual feedback to the participant to consciously control 
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the physiological body reaction may be seen to rely upon the three stages of depiction, 
awareness and learning described above. Put in other terms, Kaushik (2007) defined BFB as a 
form of self-regulation in which individuals learn to control physiological responses by 
providing them with an information signal as sensory feedback about biological conditions of 
which they may not be ordinarily aware. Biofeedback also involves the application of operant 
conditioning to gain control of visceral, somatomotor or central nervous system activities. 
4.1.  Biofeedback in Clinical Settings for Stress Hyperarousal 
 When applied to persons with over-arousal as a clinical presenting problem, BFB can 
be used as a psychophysiological assessment tool used to teach those persons methods of 
reducing their arousal (Rice, Blanchard & Purcell, 1994). In such cases, BFB fits into the 
overall stress-reduction protocol in as steps 2 and 3 of the following three steps (Sharpley, 
Guidara & Lancaster, 1996). 
1. Identifying the antecedent that causes the reactivity 
2. Assisting the participant to recognise the physiological response to that antecedent  
3. Teaching the participant new coping skills (ie, BFB) to reduce the reaction between 
the event and the physiological reactivity 
 The most common form in which BFB is provided (called its ―modality‖) in clinical 
settings is dictated by the particular physiological behaviour which is being monitored for 
change.  
 For example,  if muscle tension is the target physiological response (e.g., for people 
with tension headaches), then Electromyogram (EMG) Biofeedback is used wherein 
electrodes or sensors are applied to the specific muscle group under examination and the 
electrical signal of those muscles is presented in A/V format, typically by a line graph on a 
screen or an increasing/decreasing tone that varies with the amount of electrical activity in the 
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muscle spindles with the muscle group being examined.  For example, for a person who 
suffers from severe headaches as a result of prolonged tension of their neck muscles, BFB 
provides a depiction of the electrical activity in those neck muscles. If, as would be expected 
in such cases, the initial level of electrical activity in the neck muscles was high, then the 
client is set the task of trying to reduce that tension by (say) deep breathing, voluntary 
relaxation of the muscle group, or concentrating upon different mental imagery than that 
which is associated with the tension. In such cases, the use of purely auditory BFB can be 
efficacious due to the value of the client being able to close their eyes during this process. 
 Another commonly-used modality for BFB is Electrodermal Activity (EDA) 
Biofeedback, wherein the activity of sweat glands and the amount of perspiration on the skin 
can be indirectly assessed by sensors which measure the degree of resistance to a very small 
(in the region of 500 microvolts) electrical current that is passed between two electrodes on 
(say) adjoining fingers of one hand. The hand is often chosen in such cases because of the 
tendency of primates to sweat on their extremities during periods of SNS arousal instigated 
by environmental stress.  However, while EDA is more effective as a measure of SNS 
activity than any other physiological index, it has the major limitation of being unsuitable for 
the third stage of BFB (i.e., self-control) due to the extended presence of sweat on the hands, 
which prevents the person who is receiving this BFB from learning how to reverse that sweat 
production as a means of controlling SNS arousal to stressors in the environment. This is an 
important limitation when dealing with clients who present with anxiety in the form of 
exaggerated SNS arousal. As will be explained below, HR feedback is more efficient for this 
process. 
 Skin temperature (ST) Biofeedback is another method for measuring SNS activity 
because blood flow to the extremities is reduced when SNS arousal occurs. This reduction in 
blood flow causes reductions in skin temperature, and so can be a reliable measure of anxiety. 
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However, as for EDA activity, there is an inherent limitation in using ST BFB for teaching 
clients to self-control anxiety because of the slow rate of reduction in skin temperature that 
occurs when SNS arousal occurs, and in skin temperature increase when relaxation occurs. 
This skin temperature change process can take several minutes, even as much as 15-20 mins, 
thus making it relatively difficult for clients to match the increase in skin temperature with 
their cognitive or behavioural attempts to reverse the decrease in skin temperature due to SNS 
arousal. However, it should be noted that, when clients do learn to control their skin 
temperature, it appears to be a profound form of self-control learning which they report to be 
highly efficacious for them. 
 Electroencephalograph (EEG) Biofeedback or Neurofeedback measures the 
frequency and relative amounts of brain electrical activity across various sites on the skull. 
Although not a facet of this thesis (and a very complicated procedure) put simply, EEG BFB 
is often used to train clients to induce alpha-wave activity (about  8 to 13 Hz) instead of beta-
wave activity (13+ Hz) when they are experiencing the symptoms of cognitive stress arousal 
such as racing thoughts, mental confusion, and inability to make decisions.  Alpha-wave 
activity is associated with a pleasant feeling of mental relaxation and occurs when a person is 
lightly drowsing or daydreaming. 
 As mentioned above, this thesis reports on the use of Heart Rate (HR) Biofeedback 
to assist clients to reduce their anxiety levels. During HR BFB, an electrode applied to a 
finger or earlobe monitors blood flow from the cardiac pulse as an indicator of heart rate (HR) 
and heart rate reactivity (HRR). HR is simply the reciprocal of the inter-beat interval between 
successive R-R spikes that are occasioned by electrical stimulation of the cardiac muscle by 
electrical signals from the brain that contact the heart at the sino-atrial node, a bundle of 
nerve fibres on the surface of the heart. Thus, instead of depicting the inter-beat intervals in 
milliseconds, the number of beats per minute is shown on a pc screen or by auditory methods. 
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HRR refers to the increase in HR following the onset of a stressor, and is usually calculated 
by comparing the mean HR during the minute immediately preceding the stressor with the 
mean HR during the minute immediately following the onset of the stressor (Sharpley & 
Gordon, 1999). HRR has been described by Sharpley, Scuderi and Heffernan (1989) as the 
predisposition of humans to react to the onset of a physical or psychological trigger by rises 
in heart rate which exceed those required by the motor responses triggered by the stressor. 
That is, HRR is most often used to refer to the ‗psychological‘ aspect of an individual‘s HR 
response to a stressful event. 
4.2. Types of Disorders Suited for Treatment by Biofeedback 
 A method for evaluating the effectiveness of BFB for a range of disorders has been 
developed by the Association for Applied Psychophysiology based on research from Moss 
and Gunkelman (2002) and LaVague et.al (2002), and is presented in Table 1. 
Table 1 
Effectiveness of Biofeedback 
Level  Description of efficacy level of 
biofeedback 
Disorder 
Level 1 Not empirically supported: Supported only 
by anecdotal reports and/or case studies in 
non-peer reviewed venues. 
Autism 
Eating Disorders 
Multiple Sclerosis 
Spinal Cord Injury 
Level 2 Possibly Efficacious: At least one study of 
sufficient statistical power with well 
identified outcome measures, but lacking 
randomized assignment to a control 
condition internal to the study. 
Asthma 
Cancer and HIV, Effect on 
Immune Function 
Cerebral Palsy 
Chronic Obstructive Pulmonary 
Disease 
Depressive Disorders 
Diabetes Mellitus 
Fibromyalgia 
Foot Ulcers 
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Hand Dystonia 
Irritable Bowel Syndrome 
Mechanical Ventilation 
Motion Sickness 
Myocardial Infarction 
Post-Traumatic Stress disorder 
Raynaud's Disease 
Repetitive Strain Injury 
Stroke 
Tinnitus 
Urinary Incontinence in Children 
Level 3 Probably Efficacious: Multiple 
observational studies, clinical studies, wait 
list controlled studies, and within subject 
and intrasubject replication studies that 
demonstrate efficacy. 
Alcoholism/Substance Abuse 
Arthritis 
Chronic Pain 
Epilepsy 
Faecal Elimination Disorders 
Headache- Paediatric Migraines 
Insomnia 
Traumatic Brain Injury 
Vulvar Vestibulitis 
Level 4 Efficacious a.) In a comparison with a no-
treatment control group, alternative 
treatment group, or sham (placebo) control 
utilizing randomized assignment, the 
investigational treatment is shown to be 
statistically significantly superior to the 
control condition or the investigational 
treatment is equivalent to a treatment of 
established efficacy in a study with 
sufficient power to detect moderate 
differences, and 
b.) The studies have been conducted with a     
population treated for a specific problem, 
for whom inclusion criteria are delineated 
in a reliable, operationally defined manner, 
and 
c.) The study used valid and clearly 
specified outcome measures related to the 
problem being treated and 
d.) The data are subjected to appropriate 
data analysis, and 
e.) The diagnostic and treatment variables 
and procedures are clearly defined in a 
Anxiety 
Attention Deficit Disorder 
Headache- Adult 
Hypertension 
Urinary Incontinence in Males 
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manner that permits replication of the 
study by independent researchers, and 
f.) The superiority or equivalence of the 
investigational treatment has been shown 
in at least two independent research 
settings. 
Level 5 Efficacious and specific: The 
investigational treatment has been shown 
to be statistically superior to credible sham 
therapy, pill, or alternative bona fide 
treatment in at least two independent 
research settings. 
Urinary Incontinence in Females 
 
 Using these criteria, Kuashik (2007) performed a meta-analysis on the effectiveness 
of BFB for the treatment of a range of disorders and found that BFB is effective as a 
treatment modality for anxiety, headaches, hypertension, coronary heart disease, epilepsy, 
chronic pain, constipation, faecal incontinence, irritable bowel syndrome, bronchial asthma, 
diabetes mellitus, cardiovascular rehabilitation and post-stroke rehabilitation.  (see Appendix 
C for level 5 efficacy studies for BFB and Appendix D for level 4 efficacy studies for BFB) 
 However, most studies reviewed in this thesis acknowledge that BFB is not always 
effective when used as the only intervention, but that the efficacy rate of BFB biofeedback is 
increased when BFB is combined with another treatment modality, such as various forms of 
psychotherapy or relaxation therapy. 
4.3. Biofeedback and Anxiety 
  Yucha and Gilbert (2004) published an efficacy rating for the use of BFB as a 
treatment for different disorders, and rated BFB for anxiety as ‗efficacious‘. However, 
although that review of the literature suggested that EEG was the most common form of BFB 
treatment for anxiety disorder, it is noteworthy that, in those cases where EEG was applied as 
a treatment for anxiety, it was delivered alone, as the sole treatment. However, as noted 
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above, BFB has been shown to be most effective when combined with other treatments.  
Further, behaviourally-oriented and psychosocial guidelines for the effective treatment of 
mental disorder (Ford & Kidd, 1998; Burns, Hoagwood & Mrazek, 1999; Kessler et.al, 2005) 
recommend that multi-modal treatments are necessary for generalisation of skills learned in 
the clinic environment. Therefore, biofeedback should be part of a treatment package and not 
applied alone.  
 When deciding on which BFB modality to use with a specific disorder, it is crucial to 
consider the self-efficacy of clients in their capacity to create positive internal changes. For 
clients with anxiety, any delay or failure to create such changes can negatively impact on 
their treatment success. Therefore, in choosing the best treatment, the BFB modality should 
consider the influence of self-efficacy. However, EEG (due to requiring a longer learning 
time) might not be the best option for clients with intense anxiety and who require fairly fast 
treatment effects to become apparent. Therefore, in this study it was decided to use HR BFB 
as a means of training clients to become aware of their SNS-arousal states, how those states 
might be associated with specific anxiety-linked stressors, and thence to learn methods of 
reducing HR (and SNS arousal) that are generalisable to their usual working/living 
environments. 
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CHAPTER 5 
Method  
5.1  Participant Group  
Participants were required to fulfil four criteria in order to be eligible for inclusion in 
this study. They were required to be a minimum age of 16 years, fulfil the DSM-IV-TR 
(APA, 2000) criteria for a formal diagnosis of Generalised Anxiety Disorder (GAD), and 
exhibit general good health (i.e., no symptoms of major cardiovascular, respiratory or 
endocrine illness for which they were receiving medical treatment). The fourth inclusion 
criterion required that participants not use any prescribed anxiolytic medication, autonomic 
nervous system-altering substances or illicit substances for the duration of their involvement 
in the study. All participants signed a disclaimer stating that they were not using medications 
of this type. Intake of stimulants (e.g., caffeine) and alcohol intake were monitored via verbal 
report to the researcher who recorded weekly caffeine and alcohol intake for each participant.  
Twenty-one adults, comprising four academic staff, five general staff, and twelve 
student volunteers, underwent an initial screening interview to establish their eligibility for 
inclusion in this study (see Appendix E: Inclusion/Exclusion Criteria). Of the 21 initial 
respondents to an invitation to volunteer for the study, four were excluded due to the presence 
of an anxiety-based diagnosis other than GAD (i.e. Post-Traumatic Stress Disorder, 
Obsessive Compulsive Disorder, and Social Phobia), one was excluded due to presence of a 
physical illness (Myocardial Infarction), two were excluded as a consequence of using 
prescribed medication (i.e. Beta Blockers and Benzodiazepines) and two were excluded as a 
consequence of  illicit drug use (i.e. Cannabis and Amphetamines). One initial respondent 
was excluded due to presence of a physical illness as well as using prescribed medication (i.e. 
Hyperthyroidism and Thyroxin). Therefore, the participants for this study were 11 adults who 
worked or studied at a private University on the Gold Coast in Queensland. Of these 11 
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participants, four (36%) were male and seven (64%) were female. They ranged in age from 
18 to 57 years, with a mean age being 33.6 years (SD = 10.97). Ethnicity trends for the 
participants showed that the majority (i.e., seven) were Australians, two were Norwegians, 
one was Malaysian, and one Chinese. Below is a detailed description of each participant for 
this study. 
 5.1.1 Participant 1 
 Participant 1 was an 18 year old female studying an undergraduate degree in 
Psychology, and she reported symptoms which complied with the DSM-IV-TR (APA, 2000) 
criteria for a diagnosis of GAD. She reported being in good physical health and stated that 
she did not engage in stimulant or illicit drug use. The only medication she used during the 
duration of this study was paracetamol for headaches.  This participant was single, did not 
have any dependants and lived alone. Participant 1 underwent counselling for approximately 
six months, five years prior to this study, to resolve personal difficulties pertaining to 
childhood sexual abuse. The psychotherapeutic interventions used to assist this participant 
included Cognitive Behaviour Therapy and Hypnosis. Participant 1 reported that she 
experienced moderate to severe anxiety ―in all aspects of life‖. She mentioned a strong 
history of anxiety-related conditions in the extended family. Her mother and two sisters were 
medically treated for anxiety-related disorders and her two sisters were also seeing therapists.  
Participant 1 reported that she did not undertake any form of exercise and did not compete in 
any sport 
 5.1.2 Participant 2 
 Participant 2 was a 53 year old male senior academic working in the Faculty of 
Business at the University in which this study was undertaken. He complied with the 
diagnostic criteria for GAD as defined by the DSM-IV-TR (APA, 2000). He reported being 
in good health and stated that he did not engage in stimulant or illicit drug use. He had been 
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diagnosed with Hypercholesterolemia and treated with a cholesterol-lowering drug. He was 
married for 27 years and had four children, two male and two female, aged between 19 and 
25 years. Participant 2 reported that his relationships with his wife and children were positive 
and supportive. Participant 2 reported that he had not undergone any previous medical 
treatment or psychological interventions for his anxiety. He had no family history of any 
anxiety-related conditions. He mentioned that, due to a very heavy workload and extra 
responsibilities, he had noticed an increase in his anxiety levels which had become 
progressively more severe during the two years prior to the study. Participant 2 reported that 
he worked seven days a week and his exercise regime consisted of a brisk walk for 
approximately two kilometres once a week. 
 5.1.3 Participant 3 
Participant 3 was a 20 year old female student studying an undergraduate degree in 
Information Technology and she presented with the combination of symptoms necessary for a 
diagnosis of GAD as defined by the DSM-IV-TR (APA, 2000). She also suffered from 
Irritable Bowel Syndrome but was not on any medical treatment for this condition during the 
duration of the study. Participant 3 consumed one cup of instant coffee every morning and 
reported that she did not engage in illicit drug use. She was in a defacto relationship, sharing 
an apartment with her partner.  She reported a stable, supportive relationship. Participant 3 
reported that she had not undergone any previous medical treatment or psychological 
interventions for her anxiety. Participant 3 had a history of suffering from panic attacks and 
experienced the last attack approximately one year prior to the commencement of the study. 
She described herself as being ―highly strung‖ with a low grade of anxiety present all the 
time and reported that her mother and grandmother both suffered from anxiety-related 
conditions. Her physical fitness schedule consisted of three to four gym sessions per week, 
40 
 
 
 
including weight training and aerobic exercise. The duration of each session was 
approximately one hour.   
 5.1.4 Participant 4 
 Participant 4 was a 57 year old male senior academic working in the Faculty of 
Information Technology who complied with the diagnostic criteria for GAD as defined by the 
DSM-IV-TR. (APA, 2000). He reported being in good physical health but being very 
sensitive to any stimulants including caffeine and therefore avoided coffee and other caffeine-
based beverages. He was diagnosed with Hypertension four years prior to this study and was 
being treated with anti-hypertensive medication (not a β-receptor blocker that would have 
affected the autonomic nervous system). No other medication or illicit substances were 
consumed during the duration of the study. He had been married for 34 years and had seven 
children, three male and four female, aged between 22 and 32 years. He reported that the 
relationship has been stable without any major problems. Participant 4 reported that he had 
not undergone any previous medical treatment or psychological interventions for his anxiety. 
He reported that, due to a heavy workload, he developed anxiety-related symptoms which 
had become progressively more severe during the previous 16 months. His physical fitness 
schedule consisted of playing tennis most Saturdays for approximately 3 hours with no 
opportunity to partake in any other form of exercise. 
 5.1.5 Participant 5 
Participant 5 was a 39 year old female junior academic in the Faculty of Humanities 
and Social Sciences who fulfilled the criteria for a diagnosis of GAD as defined by the DSM-
IV-TR (APA, 2000). She suffered from mild Asthma but did not receive any medical 
treatment for this condition during the duration of the study. Participant 5 consumed three 
cups of coffee per day but did not report the use of any other medication or illicit substances 
during the duration of the study. She was in a defacto relationship and shared a house with 
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her partner; this participant reported that she did not have any children. Participant 5 reported 
that the relationship was unstable and that she and her partner had two trial separations during 
the previous year. She reported suffering from moderate anxiety-related symptoms for 
approximately the last 15 years. These symptoms had started to affect most aspects of her life 
two years prior to commencement of this study. Participant 5 reported that she had not 
undergone any previous medical treatment or psychological interventions for her anxiety. She 
mentioned a strong history of anxiety-related conditions in her extended family. Her father, 
mother, sister and brother were medically treated for anxiety-related disorders and, in 
addition to taking medication, her father and mother were seeing therapists. Participant 5 
attended the gym on an irregular basis and did not partake in any other form of exercise. 
 5.1.6 Participant 6 
 Participant 6 was a 28 year old male student studying an undergraduate degree in 
Languages and he complied with the diagnostic criteria for GAD as defined by the DSM-IV-
TR (APA, 2000). Participant 6 reported leading a healthy lifestyle and avoided all stimulants. 
He did not use any medication during the duration of the study and reported no illicit drug 
use. He was in a defacto relationship sharing a unit with his partner and had no dependants. 
He described their relationship as being stable. He described himself as being a very anxious 
and nervous child growing up in an unstable family with his parents going through a divorce 
when he was six years old.  He had undergone medical treatment for persistent anxiety-
related symptoms which consisted of Benzodiazepines but had ceased this medication due to 
addiction problems. Participant 6 had not undergone any previous psychological 
interventions. He suffered from severe anxiety-related problems on a daily basis.  Participant 
6 reported that he had no family history of any anxiety-related conditions and that he did not 
partake in any regular physical exercise.  
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 5.1.7 Participant 7 
  Participant 7 was a 24 year old female student studying an undergraduate degree in 
Business Management. She complied with the diagnostic criteria for GAD as defined by the 
DSM-IV-TR (APA, 2000) and reported symptoms of gastro-intestinal discomfort but 
described her general health as being good. Participant 7 consumed one to two caffeine-
containing soft drinks per day but reported no use of illicit substances or any other 
medication. She was single, did not have any dependants and lived alone. She reported 
suffering from anxiety from the age of 11 years. Participant 7 reported that she had not 
undergone any previous medical treatment or psychological interventions for her anxiety.  
She mentioned that both her father and sister suffered from anxiety-related disorders and that 
both were being medically treated in an effort to control their symptoms. Participant 7 
reported that she swam four times per week for approximately 45 minutes and went to the 
gym three times per week doing cardio vascular exercises for 60 minutes per class.  
 5.1.8 Participant 8 
Participant 8 was a 32 year old female working as an administrative staff person in the 
Faculty of Law who complied with the diagnostic criteria for a GAD as defined by the DSM-
IV-TR (APA, 2000). She suffered from mild Asthma but was not receiving any medical 
treatment for this condition. She did not use any medication or illicit drugs during the 
duration of the study. Participant 8 reported drinking two cups of coffee per day and two 
glasses of red wine at night. She had been married for four years and had a five year old boy. 
She described her relationship as being happy and stable. Participant 8 described an unstable 
childhood with her parents going through a divorce when she was five years old and reported 
experiencing an incident of sexual abuse at the age of seven. She underwent counselling as a 
child but could not identify or describe the specific therapy used during these sessions. This 
participant reported that the current anxiety-related symptoms she experienced had been 
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triggered by a panic attack four years ago. There was no family history of any anxiety-related 
symptoms. Participant 8 did not partake in any regular physical activities or in any sports. 
 5.1.9 Participant 9 
 Participant 9 was a 23 year old female student studying an undergraduate degree in 
Information Technology who fulfilled the criteria for a diagnosis of GAD as defined by the 
DSM-IV-TR (APA, 2000). She reported being in good physical health and stated that she did 
not engage in stimulant or illicit drug use, stating that she refrained from drinking caffeinated 
and alcoholic drinks.  The only medication she used during the duration of the study was 
aspirin for headaches. She had been married for two years and had two children, a four year 
old boy and a two year old girl. Participant 9 reported her relationship as stable and 
uneventful. Participant 9 described herself as having been a sensitive and anxious child and 
reported experiencing symptoms of anxiety throughout her life. She did not report receiving 
any previous psychological or medical interventions for her anxiety-related symptoms. There 
was no family history of any anxiety related symptoms. She reported living a healthy lifestyle 
which consisted of regular yoga sessions, meditation and a healthy diet.  
 5.1.10 Participant 10 
  Participant 10 was a 30 year old female working as a cleaner at Bond University and 
she complied with the diagnostic criteria for GAD as defined by the DSM-IV-TR (APA, 
2000). She was HIV positive and had been receiving antiviral medical treatment for the last 
18 months. Her general health was good and she was not receiving any other form of medical 
intervention during the duration of this study. Participant 10 stated that she did not engage in 
stimulant or illicit drug use. She consumed two cups of coffee per day. Participant 10 
reported being divorced with two children, seven and ten year old girls.  She reported that she 
had suffered from anxiety since early childhood but that her pre-existing anxiety-related 
symptoms worsened after she underwent drug rehabilitation five years prior to the study. 
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Participant 10 was not involved in any formal exercise programmes but reported being 
physically active due to her work. 
 5.1.11 Participant 11 
  Participant 11 was a 46 year old male student studying an undergraduate degree in 
Law and he reported experiencing symptoms which met the criteria for a diagnosis of GAD 
as defined by the DSM-IV-TR (APA, 2000). Participant 11 stated that he was in general good 
health but suffered from occasional headaches. He reported that he was not taking medication 
or engaging in illicit drug use but did report consuming one to two cups of coffee per day. 
This participant was divorced with two children, a boy aged 17 and a girl aged 19. Participant 
11 reported being anxious for two years prior to this study but could not identify any reason 
for the onset of anxiety-related symptoms. He reported that he had not received access to   
any medical or psychological interventions to assist him in dealing with his growing anxiety. 
Participant 11 reported that he exercised reasonably regularly by taking two to three brisk 
beach walks per week.  
5.2 Assessment Instruments 
 The ideographic assessment of participants included an initial intake interview to 
confirm the diagnosis of Generalised Anxiety Disorder according to DSM criteria. Once the 
presence of this anxiety disorder was established, the severity of anxiety and the profile of 
anxiety symptoms were measured via self-report using the Zung Self-Rating Anxiety Scale 
(1971). Finally, each participant completed a Functional Assessment interview in order to 
provide in-depth information on the particular ways in which anxiety manifested itself and 
the impacts it exerted on their day-to-day functioning. Below is a description of the 
assessment instruments employed in this assessment process. 
 
 
45 
 
 
 
 5.2.1 Zung Self-Rating Anxiety Scale (Zung, 1971) 
 To quantify the severity of the participants‘ anxiety-related symptoms, the Zung Self-
Rating Anxiety Scale (SAS) was administered individually to each participant. The SAS 
gives standardised measures of physiological, cognitive and emotional symptoms of anxiety. 
The SAS is self-administered and consists of 20 items which are divided into physiological 
(muscle tremors, physical aches and pains, weakness, palpitations, shortness of breath, 
numbness, dizziness, nausea, fatigue, urinary frequency, sweating, flushing restlessness and 
insomnia), cognitive (mental disintegration) and emotional (nervousness, fear, panic, 
trepidation, and nightmares) symptoms of anxiety (Zung,1971, 1980). The SAS is a brief and 
concise test that was used to make comparisons of participant‘s anxiety status before and 
after treatment. 
 The SAS was completed by each participant for the period of one week prior to the 
interview. Each symptom on the SAS is rated on an intensity scale as ―none or little of the 
time‖, ―some of the time‖, ―good part of the time‖, or ―most or all of the time‖. Raw scores 
are derived from these ratings and may be converted to index scores (not necessary and not 
used in this study). High raw scores indicate severe anxiety and low raw scores indicate 
moderate to low levels of anxiety. Raw scores greater than 30 indicate clinically significant 
anxiety.  
 5.2.1.1 Validity 
 The SAS is based on the DSM-II and accounts for somatic, cognitive and affective 
symptoms of anxiety (Zung, 1971) and therefore the scale‘s content validity (face validity) is 
high (Zung, 1980). The concurrent validity between the SAS and the Taylor Manifest 
Anxiety scale has been shown to be acceptable (r = .30, r = .62, p < .01: Zung, 1971, 1980) as 
well as between the SAS and the Hamilton Anxiety Scale (r = .75, p < .01; Zung, 1980, 
Sharpley, Bitsika & Efremidis, 1997). Construct validity was sound and the SAS 
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differentiated well, with a clear distinction between individuals with and without anxiety 
(Zung, 1980). 
 5.2.1.2 Reliability 
 Reliability for the SAS is clinically acceptable, ranging from 0.71 (split half: Zung, 
1971) to 0.79 (coefficient alpha: Sharpley & Rogers, 1985) and 0.85 (coefficient alpha: Zung, 
1980). Therefore, the SAS has adequate levels of internal consistency. 
 5.2.2 Diagnostic Criteria for Generalised Anxiety Disorder 
 The researcher developed a symptom checklist using the diagnostic criteria for 
Generalised Anxiety Disorder as presented in the fourth and text revised edition of the 
American Psychiatric Association‘s Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV-TR, 2000). This checklist contained the six diagnostic criteria for GAD and the six 
symptoms listed under criterion C. The DSM-IV-TR (APA, 2000) GAD checklist was 
administered at the end of the intake interview via the researcher asking each participant 
questions designed to investigate their experiences in relation to each diagnostic criterion. All 
participant responses were noted during this face-to-face interview and checked for accuracy 
by the researcher. A copy of the checklist appears in Appendix A.  
 5.2.3 Functional Assessment Interview Schedule 
 A formal interview schedule based upon Functional Assessment procedures, as 
described in Chapter 3, was developed and appears in Appendix F of this thesis. This face-to-
face interview was designed to record participant self-reported data on demographic 
information (biographical details, family history and medical history), presenting problems 
and fear responses (i.e., anxiety-related symptomatology in the participant‘s own words), 
setting events and antecedents for anxiety-based behaviours; as well as reinforcement 
processes for and functions served by these behaviours. The interview data were analysed in 
order to determine the variables which might predispose participants to engage in fear 
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responses in day-to-day life (see Appendix F for the Functional Assessment interview 
schedule). 
5.3  Methods for Measuring Change in Participant Anxiety 
 This study was designed to use two procedures to measure change in self-reported 
somatic symptoms and, to a lesser extent, cognitive/emotional indicators of anxiety. First, a 
pre- and post-treatment procedure (involving administration of the SAS and physiological 
baseline) was used to compare level and intensity of anxiety symptoms before and after 
treatment application. Second, continuous measures of heart rate were taken during sessions 
III and VII (treatment phase) in order to establish a cumulative measure of any incremental 
changes in heart rate indicating a reduction in physiological reactivity (see Table 2 below for 
summary of measurement strategies). These HR data were also used to calculate Resting 
Heart Rate (RHR) and Respiratory Sinus Arrhythmia (RSA), which is defined as the 
difference between maximum HR when inhaling (HR comes under the control of the 
Sympathetic Nervous System [SNS] when inhaling) and the minimum HR when exhaling 
(when HR comes under the control of the Parasympathetic Nervous System [PNS]). Thus, 
RSA is depicted in beats per minute difference between maximum HR and minimum HR 
during a breathing cycle. RSA has been used as an index of SNS-PNS ‗balance‘ in studies of 
psychological stress and anxiety (Dishman et al, 2000; Pancheri et al, 2002), and may be used 
as a method of providing immediate feedback to participants via the depiction of their HR on 
a computer screen. Such training procedures have shown their efficacy in helping people who 
are anxious to reduce their RHR and HR during stressful events in the clinic and workplace 
(Sharpley, 1994b).  
 The Functional Assessment process was used only at pre-treatment to conduct an 
idiographic investigation of anxiety. 
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Table 2:  
Summary of Measurement Strategies 
Treatment Phase Assessment Focus Assessment Instrument 
Pre-Treatment Level and intensity of anxiety Zung Self-Reported Anxiety 
Scale 
Anxiety as a fear response and 
maintaining variables 
Functional Assessment 
Interview 
Somatic anxiety via heart rate Bioview series IV, Zencor® 
During Treatment Graduated variation in anxiety Bioview series IV, Zencor® 
Post-Treatment Level and intensity of anxiety Zung Self-Report Anxiety 
Scale 
Somatic anxiety via heart rate Bioview series IV, Zencor® 
 
5.4  Procedure 
 5.4.1  Recruitment 
 Participants were recruited from the researcher‘s campus. An e-mail was send to all 
staff and students inviting their participation in this study (see Appendix G for e-mail to staff 
and students). A total of 21 staff members and students responded. After this initial interest 
was demonstrated, a receptionist at the Bond University Counselling Clinic recorded the 
potential participant‘s contact details. Each potential participant was then contacted via 
telephone by the researcher in order to provide an explanation of the study‘s aims, procedures 
and anticipated time commitments as outlined in the Explanatory Statement for the research 
project. Those people who expressed interest in participating in the study were invited to 
attend an intake interview to establish whether they met the inclusion criteria as specified 
below.  
 Criteria for inclusion were: having a diagnosis of GAD, being 16 years of age or 
older, having general good health, and not receiving treatment for any medical condition that 
might influence their neurological or cardiovascular responses. In addition, participants were 
asked not to use Autonomic Nervous System stimulants during the duration of the study.   
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 On arrival at the clinic, the receptionist handed each potential participant an intake 
form (see Appendix H for the Intake Form).  Each potential participant then met the 
researcher, and was taken to the interview and treatment room for the first intake interview. 
 The potential participants were informed that the first two sessions had no therapeutic 
intent. It was made clear to them that they were under no obligation to continue with this 
study and that they could terminate their participation at any time without any repercussions. 
An Explanatory Statement was handed to participants and explained during the initial stage 
of the intake interview (see Appendix I for the Explanatory Statement: Part 1).  Due to the 
fact that all the participants were recruited from campus, and therefore could be identified at a 
future time by the researcher, the confidentiality clause outlined in the Explanatory Statement 
was emphasized. All aspects of the study were explained to potential participants and queries 
were answered.  
 If a potential participant decided to partake in this study, he/she was then handed a 
consent form (see Appendix J for the Consent Form). The consent form provided participants 
with a formal basis for confirming that they understood the explanations offered in relation to 
procedures, confidentiality, and voluntariness. All signed consent forms were collected and 
stored under lock and key for the duration of time specified by the Bond University Human 
Research Ethics Committee.  
 The participant was then familiarised with the setting and equipment. The treatment 
regime schedule was then explained in detail. If a participant decided to continue with this 
study, he/she was requested to make a follow-up appointment to commence the study. 
5.4.2  Setting, Assessment and Treatment Phases, and Biofeedback Equipment 
  5.4.2.1 Setting 
 All sessions were conducted in the Counselling Clinic at the University by the 
researcher using the same clinic room to maintain consistency in environment. The clinic 
50 
 
 
 
room was soundproofed and approximately three by four meters in size. It contained three 
chairs and a desk with biofeedback equipment on the desk. One wall was covered by a 
bookcase and there were two prints on the other walls. 
 5.4.2.2 Assessment and Treatment Phases 
 This study consisted of two phases during which the researcher administered a 
number of assessment and treatment activities. Phase one (i.e., sessions 1 and 2) focused on 
assessment and involved administration of an intake interview, Zung Self-Rating Anxiety 
Scale (see Appendix K for Zung Self-rating Anxiety Scale), and Functional Assessment 
interview. Phase two (i.e., sessions 3-7) aimed to deliver a treatment designed to create 
reduction in somatic symptomatology and assist participants in learning basic skills for 
coping with anxiety as it occurred in their day-to-day life. The treatment was applied in a 
standard manner across all participants and included use of biofeedback equipment to deliver 
respiration-based HR BFB training via Respiratory Sinus Arrhythmia Feedback. The 
treatment also employed visualisation to rehearse non-anxious behaviour in anxiety-
provoking situations, Progressive Muscle Relaxation to elicit reduction in muscle tension (see 
Appendix L for PMR script), and Systematic Desensitization to practice a competing 
response (to anxiety) in the presence of imaginal anxiety-provoking events presented to 
participants in hierarchical order from least to most anxiety inducing. Despite consistency in 
treatment strategies across participants, each strategy was tailored to the particular 
experiences and life circumstances of each participant. It is also relevant to note that 
participants were encouraged to apply their newly learned behavioural skills to deal with 
instances of anxiety as it occurred within the normal routine of their lives so as to assist in 
generalisation from the clinic to the natural environment. Table 3 below presents a summary 
of all assessment and treatment activities undertaken for the duration of the study and a more 
detailed description of those activities is contained in Appendix M of this thesis. 
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Table 3:  
Activities and Sessions for phases 1 and 2 of the Study 
Session Purpose Activities 
I Orientation of potential 
participants and detailed 
explanation of study procedures 
(session duration = 1 hour). 
Complete intake interview to 
confirm presence of GAD as 
determined by the DSM-IV-TR. 
Administer Zung SAS 
Provide participants with copy 
of the Explanatory Statement 1. 
II Idiographic assessment of anxiety 
in relation to investigation of fear 
response and its maintaining 
variables (session duration = 1 
hour). 
 
Final check on accuracy of 
researcher notes on anxiety 
symptomatology to confirm or 
reject presence of GAD. 
For participants who did not 
meet the inclusion criteria for 
the study, offer alternative 
counselling assistance. 
Provide participants with copy 
of the Explanatory Statement 2. 
Complete Functional 
Assessment interview for GAD. 
III Introduce process for biofeedback 
training (session duration = 45 
minutes). 
Establish baseline measure in 
Heart Rate and RSA. 
Initiate respiration-based 
training using an electrode and 
computer screen to assist 
participant monitoring of 
changes in heart rate. 
Use of verbal cues to present 
participant with anxiety-
provoking event whilst 
prompting him her to keep 
respiration even. 
IV Pair biofeedback training with 
visualisation technique (session 
duration = 45 minutes). 
 
Review and retrain (if 
necessary) participant practice 
of techniques learned in session 
III. 
Introduce visualisation of 
anxiety-provoking event to 
shape distraction from salient 
features of that event. 
Engage in visualisation whilst 
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connected to an electrode for 
heart rate and viewing 
physiological changes on the 
computer screen. 
V Pair biofeedback training with 
Progressive Muscle Relaxation 
(PMR) (session duration = 1 
hour). 
Review and retain (if necessary) 
participant practice of 
techniques learned in session 
IV. 
Introduce PMR to assist 
participant capacity to 
discriminate between subjective 
feelings of muscle tension and 
muscle relaxation. 
Engage in PMR whilst 
connected to an electrode for 
heart rate and viewing 
physiological changes on the 
computer screen. 
VI Pair biofeedback training with 
exposure to tailored Systematic 
Desensitisation technique (session 
duration = 1 hour). 
 
 
Review and retain (if necessary) 
participant practice of 
techniques learned in session V. 
Expose participant to 
individually-created anxiety-
inducing hierarchy containing 
events extracted from the 
Functional Assessment 
interview. 
Use verbal instructions to 
present events from least to 
most distressing whilst cueing 
the participant to engage in 
PMR as a competing response 
to anxiety to re-establish calm. 
Engage in SD whilst connected 
to an electrode for heart rate 
and viewing physiological 
changes on the computer 
screen. 
VII Use biofeedback training in 
combination with all previously 
learned behavioural skill 
techniques (session duration = 1 
hour). 
Review participant proficiency 
in use of skills taught in 
sessions III to VI. 
Instruct participant to engage in 
visualisation, PMR, and SD 
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whilst connected to an electrode 
for heart rate and viewing 
physiological changes on the 
computer screen. 
 
__________________________________________________________________________ 
 5.4.3 Biofeedback Equipment  
 Heart Rate and Respiratory Sinus Arrhythmia (RSA) data were collected via 
BIOVIEW series IV (Zencor®). For pre-and post-treatment collected of RSA for statistical 
calculations and additional reliability surface electrocardiograph (ECG) electrodes 
(BlueSensor, Ambu) were applied to the participants‘ left and right wrists after skin 
preparation of cleaning with methylated spirits. Data were downloaded via the HR VIEW 
program to a computer and analysed to produce statistical summaries. Training sessions used 
a less-invasive device for collection of heart rate via pulse (BIOVIEW IV), consisting of an 
earclip to the lobe of the participants‘ left ear. Their pulse data were collected and displayed 
on the computer screen as an ongoing trace because it enables the client to move his/her 
hands without confounding the ECG signal that is collected when surface electrodes are 
applied to the participants‘ wrists. Thus, this equipment and sensors enable relatively non-
invasive collection of the effects of the SNS and PNS upon the participants‘ heart rate and 
RSA. 
 Treatment was based upon the application of audio-visual feedback via a computer 
screen of the participants‘ heart rate and RSA curve. This procedure has been previously 
validated in several studies. (e.g., Cowan, Kogan, Burr, Hendershot, & Buchanan, 1990; 
Reyes, del Paso, Godoy, & Vila, 1992, Sharpley, 1994a). 
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5.5 Aims of the Study 
Therefore, and as indicated in previous chapters, the present study had the aims of: 
1. Testing the applicability of Functional Analytic Assessment methods for 
understanding anxiety symptoms in a clinical sample; 
2. Describing the outcomes of that application in terms of participants‘ GAD 
symptomatology; 
3. Using RSA-based BFB to reduce  Resting Heart Rate; 
4. Using RSA-BFB, Progressive Muscle Relaxation and Systematic Desensitization 
within imaginal anxiety-provoking events to reduce GAD symptomatology; 
5. Use the Zung SAS as a method of assessing GAD symptomatology. 
Due to the ethical restraints of providing only partial treatments to actual clinical cases, there 
was no attempt to distinguish the relative effects of each of the treatments listed under point 
4. 
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CHAPTER 6 
Results of Functional Assessment and HR-Control Biofeedback Training 
6.1 Application of Functional Assessment to Eleven Cases of GAD 
 6.1.1 Functional Assessment Targets and Definitions 
 
 This chapter describes the application of Functional Assessment to eleven participants 
in order to gather in-depth information on the specific ways in which GAD impacted on their 
day-to-day functioning. As outlined in Chapter 3 of this thesis, there are very few studies 
which have applied Functional Assessment procedures to the investigation of anxiety 
disorders and the basis for this paucity is the pervasive difficulty in defining anxiety and 
further describing it in relation to specific and observable target behaviours. However, the 
literature does contain a number of suggestions which might be used to develop and trial a 
process for idiographic assessment of anxiety suitable to the Counselling context. These 
suggestions include reconceptualising anxiety as a fear response, incorporating covert or 
‗inner-skin‘ experiences as viable targets for assessment, exploring distal antecedent 
variables (i.e., setting events) as well as proximal antecedent variables, and ensuring that both 
primary reinforcement and secondary gain processes are assessed.  
 Therefore, the process designed to conduct a trial application of Functional 
Assessment for GAD and to describe the specific experiences relevant to each participant 
consisted of five procedures listed as: 1) defining the fear response by subdividing it into 
specific covert and overt response units; 2) measuring the fear response in relation to four 
dimensions of frequency, duration, intensity, and latency; 3) identifying the setting events 
and proximal antecedents thought to trigger the fear response; 4) establishing whether post-
behaviour consequences result in positive reinforcement or negative reinforcement (social 
and/or automatic); and 5) determining the functions of the fear response.  
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 In addition to explicitly stating data-recording targets, this chapter presents 
operationalised definitions for those targets in the sequence they appeared in the semi-
structured Functional Assessment interview (see: Procedures, page 46 for a description of the 
interview). The first two data-recording targets (i.e., dimensions, specific anxiety behaviours) 
related to the fear response itself and aimed to provide information on its occurrence as well 
as its topography or appearance.  
 Target 1, referred to as Dimensions, gathered data on the possible frequency (i.e., 
number of fear responses in one day), duration (i.e., time period for each instance of fear 
response), intensity (i.e., severity of each fear response as rated on a ten-point scale ranging 
from 1 [minimum] to 10 [maximum]), and latency (i.e., time gap between onset of fear-
evoking stimulus and start of fear response). It is relevant to note that, because there was no 
clear direction in the literature on the selection of dimensions particularly suited to measuring 
anxiety, it was decided that all four dimensions would be trialled. Target 2, referred to as Fear 
Response Units, examined the specific overt (i.e., physical and/or verbal) and covert (i.e., 
‗inner skin‘ somatic and cognitive/emotion) behaviours associated with the fear response. 
Target 3, referred to as Fear Response Triggers, gathered information on the setting events 
(i.e., distal antecedents) and antecedents (i.e., locations, interactions, and tasks) thought to 
contribute to instances of the fear response. Target 4, referred to as Fear Response 
Reinforcement Processes, aimed to identify the major reinforcement processes which 
appeared to strengthen the fear response. Those reinforcement processes were classified in 
relation to whether they were social (i.e., linked to the external environment) or automatic 
(i.e., linked to some change in internal state), positive (i.e., resulting in onset of a liked 
outcome) or negative (i.e., resulting in removal of an aversive outcome), and primary (i.e., 
occurring immediately following the fear response) or secondary (i.e., some gain occurring at 
some temporal distance from the fear response). Target 5, referred to as Functions, sought to 
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examine the purpose being served by the fear response in order to determine its adaptive 
value to participants. Possible functions of the fear response were listed as escape, avoidance, 
internal change – somatic, internal change – cognition/emotion, attention, and access to 
preferred activity (see Table 4 below for the structure used to record data during the 
Functional Assessment process). 
Table 4:  
Functional Assessment Process for GAD as a Fear Response 
Target Factors Investigated 
1. Fear Response Dimensions Frequency, duration, intensity, and latency 
2. Fear Response Units Overt and covert behaviours 
3. Fear Response Triggers Setting events and proximal antecedents 
4. Fear Response Reinforcement Processes  Social positive and negative reinforcement, 
automatic social and negative reinforcement, 
primary reinforcement, and secondary gains 
5. Fear Response Functions Escape, avoidance, escape, avoidance, internal 
change–somatic, internal change–
cognition/emotion, attention, and access to 
preferred activity 
 
6.2 Individual Functional Assessment Results 
 The Functional Assessment data gathered via semi-structured interview for all eleven 
participants are presented in the tables 5 to 15 below. Column 1 for each table remains 
consistent with the table 4 above. The second column has been altered to Participant Self-
Report and represents a summary of each participant‘s verbal description of the ways in 
which each factor investigated applied to him/her. 
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  6.2.1 Participant 1 
 This participant reported four overt symptoms (i.e. low grade tremor, stuttering, 
sweating, and insomnia) and six covert symptoms (exhaustion, neck and back pain, gastro-
intestinal disturbances, headache, and nausea) as being consistently characteristic of the fear 
responses she experienced. She was able to report on fear response dimension measures in 
relation to duration, frequency and magnitude (intensity) but could not comment on her day-
to-day experiences of anxiety in relation to latency. The participant reported on a significant 
setting event that had contributed to her vulnerability to antecedents and onset of intense fear 
responses. She identified multiple functions for anxiety (see Table 5 below for assessment 
results). 
Table 5:  
Participant 1: Functional Assessment Summary 
Target Participant Self-Report 
1. Fear Response Dimensions Duration: 5-120 min. 
Frequency: 4-5 times per day. 
Intensity: 4-6 on a 10 point scale. 
2.  Fear Response Units Overt behaviours: Low grade tremor, 
stuttering, sweating and insomnia. 
Covert behaviours: Exhaustion, neck and 
back pain, gastro-intestinal disturbance, 
headache and nausea. 
3. Fear Response Triggers Setting events: Fear of being alone with one 
male or being the only female in a group of 
males. Sexual abuse as a child. 
Antecedents: Being in close physical 
proximity to one or more males with or 
without direct interaction with them. 
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4. Fear Response Reinforcement      
Processes 
Negative social reinforcement via removal of 
close physical proximity to male(s) (aversive 
social event). 
Negative automatic reinforcement via 
reduction of intensity of fear response units 
(e.g., sweating, stuttering). 
Secondary gain linked to positive social 
reinforcement via actively taking steps to 
gain access to social support. 
Secondary gain linked to positive automatic 
reinforcement via onset of strong feelings of 
calm and relief once social support was 
secured. 
5. Fear Response Functions Escape by physical removal of self from 
social situations involving male presence. 
Avoidance by avoiding the 
cognitive/emotional and somatic discomfort 
arising from male presence. 
Internal change due to a reduction in anxiety 
intensity. 
Attention from friends and family who were 
aware of history of sexual abuse and 
provided support and sympathy. 
Access to preferred activity by seeking 
pleasurable interaction with a group of 
familiar people. 
 
 6.2.2 Participant 2 
 This participant reported three overt symptoms (i.e. tremor, irritability and insomnia) 
and four covert symptoms (dizziness, lack of concentration, severe muscle spasms of the 
neck and back and, headaches) as being consistently characteristic of the fear responses he 
experienced. He was able to report on fear response dimension measures in relation to 
duration and intensity but could not comment on his day-to-day experiences of anxiety in 
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relation to frequency and latency. The participant reported on a significant setting event that 
had contributed to his vulnerability to antecedents and onset of intense fear responses. He 
identified multiple functions for anxiety (see Table 6 below for assessment results) 
Table 6: 
Participant 2: Functional Assessment Summary 
Target Participant Self-Report 
1. Fear Response Dimensions Duration: 20-300 min. 
Intensity: 7-8 on a 10 point scale. 
2.  Fear Response Units Overt behaviours: Insomnia, irritability and 
tremors. 
Covert behaviours: Dizziness, lack of 
concentration, severe muscle spasms in the 
neck and back and headaches. 
3. Fear Response Triggers Setting events: Being promoted to a 
management position two years prior to 
participation in the study.  
Antecedents: Being at work, interacting with 
senior management and undertaking aversive 
tasks (i.e. preparing for meetings, dealing 
with ―difficult‖ staff). 
4. Fear Response Reinforcement      
Processes 
Negative social reinforcement via removal of 
self from challenging interactions and 
difficult people plus discontinuing work 
tasks. 
Negative automatic reinforcement via 
reduction of intensity of fear response units 
(e.g., tremor, irritability). 
Secondary gain linked to positive social 
reinforcement via actively seeking social 
support in the form of debriefing and voicing 
concerns to wife and family. 
Secondary gain linked to positive automatic 
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reinforcement via the onset of calm and 
relief. 
5. Fear Response Functions Escape by physical removal of self from the 
social stimuli of the work environment. 
Avoidance by avoiding cognitive/emotional 
and somatic discomfort arising from work-
related events known to include challenging 
interactions and/or difficult staff. 
Internal change due to a reduction in anxiety 
intensity. 
Access to preferred activity by seeking 
pleasurable interaction with family members. 
 
 
 6.2.3 Participant 3 
 This participant reported five overt symptoms (i.e. vomiting, dermatological problems, 
irritability, motor agitation, and insomnia) and two covert symptoms (gastro-intestinal 
discomfort, and nausea) as being consistently characteristic of the fear responses she 
experienced. She was able to report on fear response dimension measures in relation to 
duration, and intensity but could not comment on her day-to-day experiences of anxiety in 
relation to frequency and latency. The description of duration of fear response (e.g., ―most of 
the day‖) did not allow for determination of any variation due to the presence of any specific 
environmental conditions. The participant could not report on a significant setting event or 
antecedents that appeared to be associated with the onset of intense fear responses. She 
identified multiple functions for anxiety (see Table 7 below for assessment results). 
Table 7:  
Participant 3: Functional Assessment Summary 
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Target Participant Self-Report 
1. Fear Response Dimensions Duration: Most of the day. 
Intensity: 8-9 on a 10 point scale. 
2. Fear Response Units Overt behaviours: Vomiting, dermatological 
problems, irritability, motor agitation, and 
insomnia. 
Covert behaviours: Gastro-intestinal 
discomfort, and nausea. 
3. Fear Response Triggers Setting events: Nil  
Antecedents: Nil 
4. Fear Response Reinforcement      
Processes 
Negative social reinforcement via removal of 
self from the social environment once anxiety 
escalated but no information on specific 
aversive social events. 
Negative automatic reinforcement via 
reduction of intensity of fear response units 
(e.g., irritability, motor agitation). 
Secondary gain links to negative social 
reinforcement: Leaving aversive social 
environments such as work to drive home. 
Positive automatic reinforcement via the 
onset of calm and relief. 
5. Fear Response Functions Escape by physical removal of self. 
Avoidance by avoiding cognitive/emotional 
and somatic discomfort arising from 
perceived anxiety provoking activity. 
Internal change due to a reduction in anxiety 
intensity. 
Access to preferred activity by going home to 
her ―safe place‖. 
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 6.2.4 Participant 4 
 This participant reported two overt symptoms (i.e. motor agitation, and insomnia) and 
four covert symptoms (neck and back pain, palpitations, headache, and nausea) as being 
consistently characteristic of the fear responses he experienced. He was able to report on fear 
response dimension measures in relation to duration, frequency and intensity but could not 
comment on his day-to-day experiences of anxiety in relation to latency. The participant 
reported on one setting event that had contributed significantly to his vulnerability to 
antecedents and onset of intense fear responses. He identified multiple functions for anxiety 
(see Table 8 below for assessment results). 
Table 8:  
Participant 4: Functional Assessment Summary 
Target Participant Self-Report 
1. Fear Response Dimensions Duration: 2 min – several hours. 
Frequency: 4-5 time per day. 
Intensity: 6-7 on a 10 point scale. 
2.  Fear Response Units Overt behaviours: Motor agitation, and 
insomnia.  
Covert behaviours: Neck and back pain, 
palpitations, headache, and nausea. 
3. Fear Response Triggers Setting events: Being at work. 
Antecedents: Any work-related activity (i.e. 
report preparation, interactions with 
supervisors, and meeting preparation). 
4. Fear Response Reinforcement      
Processes 
Negative social reinforcement via removal of 
an aversive social environment. 
Negative automatic reinforcement via 
reduction of intensity of fear response units 
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(e.g., palpitations, nausea). 
Secondary gain linked to positive social 
reinforcement and via actively seeking of 
social support. 
Positive automatic reinforcement via the 
onset of calm and relief. 
5. Fear Response Functions Escape by physical removal of self from the 
work environment. 
Avoidance by avoiding the 
cognitive/emotional and somatic discomfort 
arising from work-related activities. 
Internal change due to a reduction in anxiety 
intensity. 
Attention through his social support network 
which included family and friends who 
provided advice and sympathy. 
Access to preferred activity by seeking 
pleasurable interaction with his family or 
going to the gym. 
  
 6.2.5 Participant 5 
 This participant reported five overt symptoms (i.e. tremor, difficulty speaking, Globus 
Hystericus, sweating, and insomnia) and two covert symptoms (fatigue and muscle tension) 
as being consistently characteristic of the fear responses she experienced. She was able to 
report on fear response dimension measures in relation to duration, frequency and intensity 
but could not comment on her day-to-day experiences of anxiety in relation to latency. The 
participant reported on significant setting events that had contributed to her vulnerability to 
antecedents and onset of intense fear responses. She identified multiple functions for anxiety 
(see Table 9 below for assessment results). 
Table 9:  
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Participant 5: Functional Assessment Summary 
Target Participant Self-Report 
1. Fear Response Dimensions Duration: 60-120 min. 
Frequency: 1-2 time per day. 
Intensity: 4-7 on a 10 point scale. 
2.  Fear Response Units Overt behaviours: Tremor, difficulty 
speaking, Globus Hystericus, sweating, and 
insomnia. 
Covert behaviours: Fatigue and muscle 
tension. 
3. Fear Response Triggers Setting events: History of negative 
interactions with her partner, physical 
presence in the work environment, and 
growing up in a ―highly-strung‖ family. 
Antecedents: Disagreement with a colleague, 
supervisor or her partner. 
4. Fear Response Reinforcement      
Processes 
Negative social reinforcement via removal of 
an aversive social event. 
Negative automatic reinforcement via 
reduction of intensity of fear responses (e.g., 
tremor, difficult speaking). 
Secondary gain linked to negative social 
reinforcement: Creating physical distance 
between self and potential sources of conflict 
and disagreement. 
Positive automatic reinforcement via the 
onset of calm and relief. 
5. Fear Response Functions Escape by physical removal of self from 
conflictual social environments. 
Avoidance by avoiding the 
cognitive/emotional and somatic discomfort 
arising from interactions and disagreements 
with supervisors, colleagues and her partner. 
66 
 
 
 
Internal change due to a reduction in anxiety 
intensity. 
Access to preferred activity by going for a 
walk on the beach. 
___________________________________________________________________________ 
 6.2.6 Participant 6 
 This participant reported four overt symptoms (i.e. tremor, vomiting, motor agitation, 
and insomnia) and four covert symptoms (malaise, loss of concentration, muscle tension, and 
nausea) as being consistently characteristic of the fear responses he experienced. He was able 
to report on his fear response only in relation to the dimension of intensity and could not 
comment on his day-to-day experiences of anxiety in relation to frequency, duration and 
latency. The participant reported on a significant setting event that had contributed to his 
vulnerability to antecedents and onset of intense fear responses. He identified multiple 
functions for anxiety (see Table 10 below for assessment results). 
Table 10:  
Participant 6: Functional Assessment Summary 
Target Participant Self-Report 
1. Fear Response Dimensions Intensity: 8-9 on a 10 point scale. 
2.  Fear Response Units Overt behaviours: Tremor, vomiting, motor 
agitation, and insomnia. 
Covert behaviours: Malaise, loss of 
concentration, muscle tension, and nausea. 
3. Fear Response Triggers Setting events: Parental divorce and parental 
arguments observed by the participant as a 
child. 
Antecedents: Any instance of conflict or 
disagreement with his partner. 
4. Fear Response Reinforcement      Negative social reinforcement via removal of 
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Processes an aversive social event. 
Negative automatic reinforcement via 
reduction of intensity of fear response units 
(e.g., tremor, loss of concentration). 
Positive automatic reinforcement via the 
onset of calm and relief. 
5. Fear Response Functions Escape by physical removal of self from 
partner. 
Avoidance by avoiding the 
cognitive/emotional and somatic discomfort 
arising from arguments or disagreements 
with his partner. 
Internal change due to a reduction in anxiety 
intensity. 
Access to preferred activity by taking his dog 
for a walk in the local dog park. 
  
 6.2.7 Participant 7 
 This participant reported five overt symptoms (i.e. vomiting, motor agitation, 
shortness of breath, tremors, and insomnia) and five covert symptoms (abdominal discomfort, 
palpitations, malaise, muscle tension, and nausea) as being consistently characteristic of the 
fear responses she experienced. She was able to report on fear response dimension measures 
in relation to duration, frequency and intensity but could not comment on her day-to-day 
experiences of anxiety in relation to latency. The participant reported on a significant setting 
event that had contributed to her vulnerability to antecedents and onset of intense fear 
responses. She identified multiple functions for anxiety (see Table 11 below for assessment 
results). 
Table 11:  
Participant 7: Functional Assessment Summary 
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Target  Participant Self-Report 
1. Fear Response Dimensions Duration: 15-20 min. 
Frequency: 1-4 time per day. 
Intensity: 6-9 on a 10 point scale. 
2.  Fear Response Units Overt behaviours: Vomiting, motor agitation, 
shortness of breath, tremors, and insomnia. 
Covert behaviours: Abdominal discomfort, 
palpitations, malaise, muscle tension, and 
nausea. 
3. Fear Response Triggers Setting events: Enrolling in a university 
degree and undertaking any type of 
university related activity. 
Antecedents: Physical presence in the 
university environment, attending to any 
university-related activity, and interacting 
with fellow students or lecturers. 
4. Fear Response Reinforcement      
Processes 
Negative social reinforcement via removal of 
an aversive social event. 
Negative automatic reinforcement via 
reduction of intensity of fear response units 
(e.g., shortness of breath, tremors). 
Secondary gain linked to positive social 
reinforcement via actively seeking social 
support. 
Positive automatic reinforcement via the 
onset of calm and relief. 
5. Fear Response Functions Escape by physical removal of self from the 
university environment. 
Avoidance by avoiding the 
cognitive/emotional and somatic discomfort 
arising from being involved in any university 
related activity. 
Internal change due to a reduction in anxiety 
intensity. 
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Attention arising from close contact and 
support from her social support network. 
Access to preferred activity by organising 
pleasurable interaction with a familiar 
person. 
___________________________________________________________________________ 
 6.2.8 Participant 8 
 This participant reported five overt symptoms (i.e. shortness of breath, occasional 
hyperventilation, blushing, tremors, and insomnia) and four covert symptoms (palpitations, 
malaise, muscle tension, and nausea) as being consistently characteristic of the fear responses 
she experienced. She was able to report on fear response dimension measures in relation to 
duration and intensity but could not comment on her day-to-day experiences of anxiety in 
relation to frequency and latency. The participant reported on a significant setting event that 
had contributed to her vulnerability to antecedents and onset of intense fear responses. She 
identified multiple functions for anxiety (see Table 12 below for assessment results). 
Table 12:  
Participant 8: Functional Assessment Summary 
Target Participant Self-Report 
1. Fear Response Dimensions Duration: 10-180 min. 
Intensity: 6-7 on a 10 point scale. 
2.  Fear Response Units Overt behaviours: Shortness of breath, 
occasional hyperventilation, blushing, 
tremors, and insomnia 
Covert behaviours: Palpitations, malaise, 
muscle tension, and nausea. 
3. Fear Response Triggers Setting events: Sexual abuse as a child. 
Antecedents: Being alone in the home and 
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any other setting. 
4. Fear Response Reinforcement      
Processes 
Negative automatic reinforcement via 
reduction of intensity of fear response units 
(hyperventilation, nausea). 
Secondary gain linked to positive social 
reinforcement via actively seeking of social 
support. 
Secondary gain linked to positive automatic 
reinforcement via the onset of calm and 
relief. 
5. Fear Response Functions Escape by physical removal of self from 
isolated locations. 
Avoidance by avoiding the 
cognitive/emotional and somatic discomfort 
arising from being alone. 
Internal change due to a reduction in anxiety 
intensity. 
Access to preferred activity by seeking 
physical presence of and pleasurable 
interactions with familiar and trusted people. 
 
 6.2.9 Participant 9 
 This participant reported five overt symptoms (i.e. tremor, blushing, shortness of 
breath, irritability, and insomnia) and four covert symptoms (severe headaches, palpitations, 
dizziness, and indigestion) as being consistently characteristic of the fear responses she 
experienced. She was able to report on fear response dimension measures in relation to 
duration, frequency and intensity but could not comment on her day-to-day experiences of 
anxiety in relation to latency. The participant reported on a significant setting event that had 
contributed to her vulnerability to antecedents and onset of intense fear responses. She 
identified multiple functions for anxiety (see Table 13 below for assessment results). 
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Table 13:  
Participant 9: Functional Assessment Summary 
Target Participant Self-Report 
1. Fear Response Dimensions Duration: 20-140 min. 
Frequency: 10 times per week. 
Intensity: 4-7 on a 10 point scale. 
2.  Fear Response Units Overt behaviours: Tremor, blushing, 
shortness of breath, irritability, and insomnia. 
Covert behaviours: Severe headaches, 
palpitations, dizziness, and indigestion. 
3. Fear Response Triggers Setting events: History of high expectations 
for academic achievement from family and 
enrolling in a university degree. 
Antecedents: Physical presence in the 
university environment and attending to any 
university related activity. 
4. Fear Response Reinforcement      
Processes 
Negative social reinforcement via removal of 
an aversive social environment. 
Negative automatic reinforcement via 
reduction of intensity of fear response units 
(e.g., dizziness, palpitations). 
Secondary gain linked to positive social 
reinforcement via actively seeking social 
support. 
Positive automatic reinforcement via the 
onset of calm and relief. 
5. Fear Response Functions Escape by physical removal of self from the 
university environment. 
Avoidance by avoiding the 
cognitive/emotional and somatic discomfort 
arising from any university related activity. 
Internal change due to a reduction in anxiety 
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intensity. 
Attention from speaking with and gaining 
support and sympathy from long-term 
friends. 
Access to preferred activity by initiating and 
engaging in a pleasurable interaction with a 
familiar person. 
 _____________________________________________________________________ 
 6.2.10 Participant 10 
 This participant reported five overt symptoms (i.e. tremor, shortness of breath, 
blushing, motor agitation, and insomnia) and three covert symptoms (palpitations, indigestion, 
and headaches) as being consistently characteristic of the fear responses she experienced. She 
was able to report on fear response dimension measures in relation to duration, frequency and 
intensity but could not comment on her day-to-day experiences of anxiety in relation to 
latency. The participant reported on a significant setting event that had contributed to her 
vulnerability to the onset of intense fear responses but could not describe any distinct 
antecedents which might have influenced her behaviour. She identified multiple functions for 
anxiety (see Table 14 below for assessment results). 
Table 14:  
Participant 10: Functional Assessment Summary 
Target Participant Self-Report 
1. Fear Response Dimensions Duration: 5-360 min. 
Frequency: 2-3 times per day. 
Intensity: 3-9 on a 10 point scale. 
2. Fear Response Units Overt behaviours: Tremor, shortness of 
breath, blushing, motor agitation, and 
insomnia. 
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Covert behaviours: Palpitations, indigestion, 
and headaches. 
3. Fear Response Triggers Setting events: Prior drug addiction and her 
HIV diagnosis. 
Antecedents: None reported 
4. Fear Response Reinforcement      
Processes 
Negative social reinforcement via removal of 
an aversive social event when she has to 
interact with strangers or work colleagues. 
Negative automatic reinforcement via 
reduction of intensity of fear response units 
(e.g., tremor, palpitations). 
Secondary gain linked to positive social 
reinforcement via actively seeking social 
support. 
Secondary gain linked to positive automatic 
reinforcement via the onset of calm and 
relief. 
5. Fear Response Functions Escape by physical removal of self from 
interactions with strangers or colleagues. 
Avoidance by avoiding the 
cognitive/emotional and somatic discomfort 
arising from a social or public event. 
Internal change due to a reduction in anxiety 
intensity. 
Attention gained from the support and 
sympathy offered by family members. 
Access to preferred activity by seeking 
pleasurable interaction with her family. 
 
 6.2.11 Participant 11 
 This participant reported three overt symptoms (i.e. motor agitation, tremors, and 
insomnia) and five covert symptoms (nausea, indigestion, malaise, loss of concentration and, 
muscle tension) as being consistently characteristic of the fear responses he experienced. He 
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was able to report on fear response dimension measures in relation to duration, frequency and 
intensity but could not comment on his day-to-day experiences of anxiety in relation to 
latency. The participant reported on a significant setting event that had contributed 
significantly to his vulnerability to antecedents and onset of intense fear responses. He 
identified multiple functions for anxiety (see Table 15 below for assessment results). 
Table 15:  
Participant 11: Functional Assessment Summary 
Target Participant Self-Report 
1. Fear Response Dimensions Duration: 10-15 min. 
Frequency: 2-3 times per day. 
Intensity: 6-8 on a 10 point scale. 
2. Fear Response Units Overt behaviours: Motor agitation, tremors, 
and insomnia. 
Overt behaviours: Nausea, indigestion, 
malaise, loss of concentration and, muscle 
tension. 
3. Fear Response Triggers Setting events: Enrolling for a university 
degree, being physically present in the 
university environment or involved in any 
university related activity. 
Antecedents: Being physically present in the 
classroom and interacting with lecturers and 
fellow students. 
4. Fear Response Reinforcement      
Processes 
Negative social reinforcement via removal 
from the university environment. 
Negative automatic reinforcement via 
reduction of intensity of fear responses. 
Secondary gain linked to to positive social 
reinforcement via actively seeking social 
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support. 
Secondary gain linked to positive automatic 
reinforcement via the onset of calm and 
relief. 
5. Fear Response Functions Escape by physical removal of self from all 
tasks and social stimuli present in the 
university environment. 
Avoidance by avoiding the cognitive and 
emotional discomfort arising from being at 
university. 
Internal change due to a reduction in anxiety 
intensity. 
Attention from his social support network. 
Access to preferred activity by seeking 
pleasurable interaction with a familiar 
person. 
 
6.3 Group Functional Assessment Results 
Table 16 
Group Functional Assessment Results 
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 The Functional Assessment of GAD was intended to assist in determination of the 
specific experiences of individual participants in order to account for the variation in 
symptomatology that is not possible by simply allocating a diagnostic label. It was also 
intended that the Functional Assessment data be reviewed in relation to depth of self-reported 
descriptions and similarities across the group of adults who participated in this study. This 
procedure was used to identify those assessment targets most likely to be of relevance to 
idiographic investigation of this diagnostic category. The group review of data also aimed to 
detect any assessment targets that did not succeed in eliciting information on participant 
responses because they were possibly not suited to their experiences. Each Functional 
Assessment target is discussed below in relation to group trends. 
 The findings for fear response dimensions (assessment target 1) indicated that 
participants were most able to describe occurrences of anxiety in relation to duration (i.e., 
minutes taken in each instance of fear response) and intensity (i.e., rating of anxiety 
magnitude on a 10-point scale). The most detailed and readily delivered descriptions were 
elicited in relation to intensity. In contrast, participants experienced difficulty in commenting 
on the frequency (i.e., number of fear responses per day) with which fear responses occurred 
and, at best, provided generalised responses such as ―most of the day‖ or ―the majority of 
time‖. Interestingly, researcher queries on latency (i.e., stimulus—anxiety onset time gap) 
were consistent in their incapacity to gather information. Even participants who were 
proficient in recognising the antecedents which caused them to become anxiety, reported that 
they were unable to describe their responses in relation to latency. 
 The findings for fear response units (assessment target 2) suggested that participants 
reported a range of covert behaviours with most commonality in experiences of muscle 
tension and back pain (73 percent), gastrointestinal disturbance and palpitations (55 percent), 
and headaches (54 percent). All participants described experiencing a number of overt 
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behaviours in addition to covert or ‗inner skin‘ responses with similarities in insomnia (100 
percent), tremor (82 percent), and motor agitation (55 percent). 
 The findings for fear response triggers (assessment target 3) showed that all (100 
percent) participants were able to describe setting events which they believed increased their 
vulnerability to anxiety-provoking stimuli in the environment. Just over half of the participant 
group (63 percent) were also able to discuss an antecedent known to cause an escalation in 
fear response when present in the environment. 
 The findings for fear response reinforcement process (assessment target 4) indicated 
that all four primary reinforcement processes (i.e., social positive/negative reinforcement and 
automatic positive/negative reinforcement) were reported to be relevant to strengthening fear 
responses and possibly sustaining them over time. It also appears that participant fear 
responses had become multi-functional, leading to numerous functions with avoidance, 
escape, and internal change—somatic more likely to follow instances of this response. 
Attention and access to preferred activity functions were mostly reported to occur some time 
after occurrence of the fear response as secondary gains. 
6.4  Pre- and Post-Treatment Biofeedback Training Results 
 6.4.1 Group Pre- and Post-Treatment Biofeedback Training Results 
 Raw data: Table 17 presents the raw data from each participant for the pre- and post-
training observations. There were no significant differences between male and female data 
from all these observations, allowing both genders‘ data to be collapsed for further analysis. 
Table 18 shows the mean and standard deviations for each measure for pre- versus post-
intervention for all measures. 
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Table 17 
Raw Data for all Participants for all Measures 
Participant Gender SAS Pre 
test 
SAS Post 
test 
RHR Pre 
Int 
RHR Post 
Int 
RSA Pre Int RSA Post Int 
  Raw 
Score 
Raw 
Score 
BPM BPM MSEC MSEC 
1 F 46 35 75 64 321.9 363.1 
2 M 55 37 83 64 234.9 907.7 
3 F 57 43 120 86 147.3 620.8 
4 M 52 38 124 69 98.6 919.8 
5 F 60 42 118 85 89.1 134.8 
6 M 57 47 111 96 48.5 1464.1 
7 F 58 53 116 101 81.0 698.8 
8 F 62 35 96 67 48.7 926.3 
9 F 58 41 104 80 47.8 593.1 
10 F 60 34 110 82 362.6 1085.7 
11 M 57 33 139 90 766.2 1005.8 
 
Table 18 
Means and Standard Deviation for Pre- and Post-Intervention for all Measures 
Measure Gender Mean Standard Deviation N 
SAS Pre-score        
                                  
Male 
Female 
55.2500 
57.2857 
2.36291 
5.25085 
4 
7 
SAS Post-score       
                                 
Male 
Female 
38.7500 
40.4286 
5.90903 
6.67975 
4 
7 
RHR Pre-score       
                                 
Male 
Female 
1.1425 
1.0557 
23.76798 
15.91495 
4 
7 
 RHR Post -score   
                                
Male 
Female 
79.7500 
80.7143 
15.62850 
12.43268 
4 
7 
RSA Pre-score       
                                
Male 
Female 
2.8705 
1.5691 
329.00043 
131.40101 
4 
7 
RSA Post-score     
                                
Male 
Female 
1.0744 
6.3180 
263.47808 
320.95478 
4 
7 
 
The mean SAS pre-score was 55.66 (SD = 5.17), median = 57.00, ranging from 46 to 62/80. 
The 5% trimmed mean was 55.85, only -0.19 below the sample mean, indicating negligible 
effects on the mean score from outliers in the sample. Skewness was negative (-1.11), 
suggesting a clustering at the upper end of the possible range of scores, to be expected within 
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a clinical sample. Kurtosis was 0.365, indicating a relatively flat distribution, confirmed by 
examination of the histogram. Inspection of the Boxplot revealed no outliers (i.e., more than 
1.5 box lengths from the edge of the box), and all scores were valid, but relatively high SAS 
scores. Using Zung‘s cut-off score of 36, all of the sample was experiencing ―clinically 
significant‖ anxiety (Zung, 1971). The Kolmogorov-Smirnov statistic was nonsignificant, 
indicating that the distribution was normal. The Normal Q-Q Plot was almost a completely 
straight line, and the Detrended Normal Q-Q Plot showed that most points collected around 
the zero line. Thus, the SAS pre-score data may be accepted as satisfying the requirements of 
normality for further analyses.  
 The mean SAS post-score was 39.81 (SD = 6.16), ranging from 33 to 53. The 5% 
trimmed mean was 39.46, only 0.35 lower than the sample mean and again indicating 
negligible effects from outliers. Skewness was positive, indicative of a clustering of scores to 
the lower end of the SAS range, and suggestive of an intervention effect when compared with 
the SAS pre-score data in the preceding paragraph. Kurtosis was again minor (0.596), 
indicative of a relatively flat distribution, confirmed by inspection of the histogram. There 
were no outliers and all SAS scores were valid, although comparatively lower than those 
collected pre-intervention. Zung‘s cut-off score for clinically significant anxiety showed that 
seven participants had scores above 36, a reduction of 36.4% from the pre-intervention SAS 
data. The Kolmogorov-Smirnov statistic was again nonsignificant, the Normal Q-Q Plot was 
almost a completely straight line, and the Detrended Normal Q-Q Plot showed that most 
points collected around the zero line. Thus, the SAS post-score data may be accepted as 
satisfying the requirements of normality for further analyses. Normality analysis of all other 
measures shown in Table 17 indicated that all scores from the variables shown there (i.e., 
RHR pre- and post-intervention, RSA pre- and post-intervention) were also normal for the 
purposes of further data analysis (all Kolmogorov-Smirnov statistics were non-significant). 
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 Of most interest are the changes in dependent variable scores that appear in Table 17 
and Table 18. MANOVA on SAS, RHR and RSA data from the pre- to post-intervention 
observations indicated a significant main effect (F(3,18) = 21.889, p < .001, Wilks‘ Lambda, 
partial eta squared = .785) for time of observation. As might be expected from the mean 
scores shown in Table 2, there were also significant univariate effects for SAS (F (1,21) = 
53.774, p < .001, partial eta squared = .729), RHR (F = 17.459, p < .001, partial eta squared 
= .466) and RSA (F = 21.208, p < .001, partial eta squared = .515).  These SAS and RHR 
results indicate decreases in anxiety and resting heart rate following intervention, plus an 
increase in RSA amplitude, and together show evidence of a significant and powerful 
intervention effect on these dependent variables in terms of the group‘s data. Individual Pre 
and post treatment RSA changes can be seen in the figure below. 
Figure 1. Individual pre- and post- treatment RSA (msec) changes. 
 
 However, while these are of interest and argue for the strength of the intervention 
overall, the examination of individual participants‘ data also provides an extra measure of the 
clinical efficacy of the intervention on individuals. The graph below show the individual pre 
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and post intervention RHR changes and the individual participant results for pre- and post 
SAS raw score changes. 
Figure 2. Pre- and post- intervention RHR (BPM) changes. 
 
Figure 3. Individual participant results for pre- and post- SAS raw score changes: 
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6.5 Individual Pre- and Post-Treatment Biofeedback Training Results 
 6.5.1 Participant 1 
 Participant 1 was aged 18 with self-reported symptoms of anxiety including insomnia, 
tremor, and constant feelings of exhaustion. The pre- versus post-intervention difference in 
SAS score for this participant was 11 (i.e., pre-intervention SAS score = 46 and post 
intervention SAS score = 45). This SAS score difference reflected an improved sleeping 
pattern, overall increase in energy and the disappearance of her tremor. The participant‘s pre-
intervention RHR was 75 beats per minute and 64 beats per minute at post-intervention. This 
indicated a reduction in sympathetic nervous system activity. A pre- versus post-intervention 
difference was also found for RSA (i.e., pre-intervention measure = 321.9 msec and post-
intervention measure = 363.1 msec). Overall, the findings obtained for Participant 1 show a 
decrease on all three measures of anxiety symptomatology and anxiety reactivity. 
 6.5.2 Participant 2 
 Participant 2 was aged 53 with self-reported symptoms of anxiety including insomnia, 
irritability, and headaches. The pre- versus post-intervention difference in SAS score for this 
participant was 18 (i.e., pre-intervention SAS score = 55 and post intervention SAS score = 
37). This SAS score difference reflected an improved sleeping pattern, the participant being 
less irritable and a reduction in frequency and intensity of his headaches. The participant‘s 
pre-intervention RHR was 83 beats per minute and 64 beats per minute at post-intervention. 
This indicated a reduction in sympathetic nervous system activity. A pre- versus post-
intervention difference was also found for RSA (i.e., pre-intervention measure = 234.9 msec 
and post-intervention measure = 907.7 msec). Overall, the findings obtained for Participant 2 
show a decrease on all three measures of anxiety symptomatology and anxiety reactivity. 
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 6.5.3 Participant 3 
 Participant 3 was aged 20 with self-reported symptoms of anxiety including insomnia, 
irritability, and motor agitation. The pre- versus post-intervention difference in SAS score for 
this participant was 14 (i.e., pre-intervention SAS score = 57 and post intervention SAS score 
= 43). This SAS score difference reflected an improved sleeping pattern, the participant being 
less irritable and a decrease in motor agitation. The participant‘s pre-intervention RHR was 
120 beats per minute and 86 beats per minute at post-intervention. This indicated a reduction 
in sympathetic nervous system activity. A pre- versus post-intervention difference was also 
found for RSA (i.e., pre-intervention measure = 147.3 msec and post-intervention measure = 
620.8 msec). Overall, the findings obtained for Participant 3 show a decrease on all three 
measures of anxiety symptomatology and anxiety reactivity. 
 6.5.4 Participant 4 
 Participant 4 was aged 57 with self-reported symptoms of anxiety including insomnia, 
muscle tension in his neck and back and motor agitation. The pre- versus post-intervention 
difference in SAS score for this participant was 14 (i.e., pre-intervention SAS score = 52 and 
post intervention SAS score = 38). This SAS score difference reflected an improved sleeping 
pattern and a decrease in motor agitation and muscle tension. The participant‘s pre-
intervention RHR was 124 beats per minute and 69 beats per minute at post-intervention. 
This indicated a reduction in sympathetic nervous system activity. A pre- versus post-
intervention difference was also found for RSA (i.e., pre-intervention measure = 98.9 msec 
and post-intervention measure = 919.8 msec). Overall, the findings obtained for Participant 4 
show a decrease on all three measures of anxiety symptomatology and anxiety reactivity. 
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 6.5.5 Participant 5 
 Participant 5 was aged 39 with self-reported symptoms of anxiety including insomnia, 
globus hystericus and sweating. The pre- versus post-intervention difference in SAS score for 
this participant was 18 (i.e., pre-intervention SAS score = 60 and post intervention SAS score 
= 42). This SAS score difference reflected an improved sleeping pattern and the 
disappearance of her globus hystericus and a reduction in sweating. The participant‘s pre-
intervention RHR was 118 beats per minute and 85 beats per minute at post-intervention. 
This indicated a reduction in sympathetic nervous system activity. A pre- versus post-
intervention difference was also found for RSA (i.e., pre-intervention measure = 89.1 msec 
and post-intervention measure = 134.8 msec). Overall, the findings obtained for Participant 5 
show a decrease on all three measures of anxiety symptomatology and anxiety reactivity. 
 6.5.6 Participant 6 
 Participant 6 was aged 28 with self-reported symptoms of anxiety including insomnia, 
loss of concentration and motor agitation. The pre- versus post-intervention difference in 
SAS score for this participant was 10 (i.e., pre-intervention SAS score = 57 and post 
intervention SAS score = 47). This SAS score difference reflected an improved sleeping 
pattern, improved concentration and a decrease in muscle tension. The participant‘s pre-
intervention RHR was 111 beats per minute and 96 beats per minute at post-intervention. 
This indicated a reduction in sympathetic nervous system activity. A pre- versus post-
intervention difference was also found for RSA (i.e., pre-intervention measure = 48.5 msec 
and post-intervention measure = 1464.1 msec). Overall, the findings obtained for Participant 
6 show a decrease on all three measures of anxiety symptomatology and anxiety reactivity. 
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 6.5.7 Participant 7 
 Participant 7 was aged 24 with self-reported symptoms of anxiety including insomnia, 
vomiting and motor agitation. The pre- versus post-intervention difference in SAS score for 
this participant was 5 (i.e., pre-intervention SAS score = 58 and post intervention SAS score 
= 53). This SAS score difference reflected an improved sleeping pattern and a decrease in 
motor agitation with a reduction in the frequency of vomiting. The participant‘s pre-
intervention RHR was 116 beats per minute and 101 beats per minute at post-intervention. 
This indicated a reduction in sympathetic nervous system activity. A pre- versus post-
intervention difference was also found for RSA (i.e., pre-intervention measure = 81.0 msec 
and post-intervention measure = 698.8 msec). Overall, the findings obtained for Participant 7 
show a decrease on all three measures of anxiety symptomatology and anxiety reactivity. 
 6.5.8 Participant 8 
 Participant 8 was aged 32 with self-reported symptoms of anxiety including insomnia, 
hyperventilation and blushing. The pre- versus post-intervention difference in SAS score for 
this participant was 27 (i.e., pre-intervention SAS score = 62 and post intervention SAS score 
= 35). This SAS score difference reflected an improved sleeping pattern, no episodes of 
hyperventilation and a reduction in the frequency of blushing episodes. The participant‘s pre-
intervention RHR was 96 beats per minute and 67 beats per minute at post-intervention. This 
indicated a reduction in sympathetic nervous system activity. A pre- versus post-intervention 
difference was also found for RSA (i.e., pre-intervention measure = 48.7 msec and post-
intervention measure = 926.3 msec). Overall, the findings obtained for Participant 8 show a 
decrease on all three measures of anxiety symptomatology and anxiety reactivity. 
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 6.5.9 Participant 9 
 Participant 9 was aged 23 with self-reported symptoms of anxiety including insomnia, 
severe headaches and motor agitation. The pre- versus post-intervention difference in SAS 
score for this participant was 17 (i.e., pre-intervention SAS score = 58 and post intervention 
SAS score = 41). This SAS score difference reflected an improved sleeping pattern and a 
decrease in motor agitation and a reduction in frequency and intensity of headaches. The 
participant‘s pre-intervention RHR was 104 beats per minute and 80 beats per minute at post-
intervention. This indicated a reduction in sympathetic nervous system activity. A pre- versus 
post-intervention difference was also found for RSA (i.e., pre-intervention measure = 47.8 
msec and post-intervention measure = 593.1 msec). Overall, the findings obtained for 
Participant 9 show a decrease on all three measures of anxiety symptomatology and anxiety 
reactivity. 
 6.5.10 Participant 10 
 Participant 10 was aged 30 with self-reported symptoms of anxiety including 
insomnia, shortness of breath and motor agitation. The pre- versus post-intervention 
difference in SAS score for this participant was 26 (i.e., pre-intervention SAS score = 60 and 
post intervention SAS score = 34). This SAS score difference reflected an improved sleeping 
pattern and breathing and a reduction in motor agitation. The participant‘s pre-intervention 
RHR was 110 beats per minute and 82 beats per minute at post-intervention. This indicated a 
reduction in sympathetic nervous system activity. A pre- versus post-intervention difference 
was also found for RSA (i.e., pre-intervention measure = 362.6 msec and post-intervention 
measure = 1085.7 msec). Overall, the findings obtained for Participant 10 show a decrease on 
all three measures of anxiety symptomatology and anxiety reactivity. 
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 6.5.11 Participant 11 
 Participant 11 was aged 46 with self-reported symptoms of anxiety including 
insomnia, palpitations and motor agitation. The pre- versus post-intervention difference in 
SAS score for this participant was 24 (i.e., pre-intervention SAS score = 57 and post 
intervention SAS score = 33). This SAS score difference reflected an improved sleeping 
pattern and a decrease in palpitations and motor agitation. The participant‘s pre-intervention 
RHR was 139 beats per minute and 90 beats per minute at post-intervention. This indicated a 
reduction in sympathetic nervous system activity. A pre- versus post-intervention difference 
was also found for RSA (i.e., pre-intervention measure = 766.2 msec and post-intervention 
measure = 1005.8 msec). Overall, the findings obtained for Participant 11 show a decrease on 
all three measures of anxiety symptomatology and anxiety reactivity. 
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CHAPTER 7 
Discussion and Conclusion 
7.1  Summary of Results 
 This research study aimed to evaluate the effectiveness of Functional Assessment as a 
method of understanding GAD symptoms among a sample of clinical cases, and to test for 
the effects of a combined treatment protocol that included RSA-BFB, Progressive Muscle 
Relaxation and Systematic Desensitization with imaginal anxiety-provoking events. As 
mentioned above, for ethical reasons, no attempt was made to distinguish the relative 
effectiveness of the training procedures, and so the conclusions drawn here are restricted to 
the effectiveness of the combined treatments. 
 However, prior to considering the effectiveness of the combined treatments for GAD, 
the applicability of Functional Assessment procedures as a means of understanding how 
GAD symptoms functioned for the participants in this study was clearly demonstrated. The 
diagnosis provided for each of the 11 cases under section 6.2 and the interpretation of group 
results of the Functional Assessment protocol presented under section 6.3 clearly display the 
applicability of this process with the kinds of GAD symptomatology presented by these 11 
cases. Although not previously demonstrated in such detail, it is realistic to conclude from 
these data that Functional Assessment models and processes may be profitably applied to 
GAD within counselling settings. 
 The second major aim of this project was to evaluate the effectiveness of a combined 
RSA-based BFB, Progressive Muscle Relaxation and Systematic Desensitization with 
imaginal anxiety-provoking events treatment protocol for GAD, and to evaluate that outcome 
via participant self-reports of their symptomatology, their resting heart rate data, and their 
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scores on the Zung SAS. As shown in sections 6.3 and 6.4, the successful group data were 
reflected in consistent success across each of the 11 participants, verifying the overall 
outcome in ways that may sometimes be obscured when only group results are considered. 
That is, as well as showing success in the usual way via statistical and visual analysis of the 
group means on the dependent variables (Zung SAS, RHR), the fact that all 11 cases showed 
consistent reductions in both of these DVs provides an additional level of confirmation for 
the combined training that was provided to these participants.  As may be seen from the 
results chapter prior to this discussion, all participants showed clinically significant 
reductions in their Zung SAS scores, reductions in RHR and increases in RSA, and also 
reported the reduction or disappearance of those major symptoms of GAD which had most 
troubled them before treatment. As well as consistency across the 11 participants in the study, 
the overall group results reported via MANOVA of the principal dependent variables clearly 
indicate that, at the combined level as well as the individual participant level, the treatment 
was successful in meeting its aims of reducing GAD symptoms. As well as these overall 
reductions in GAD-related symptoms, all participants also reported their satisfaction with the 
treatment provided to them, and commented that they would recommend the treatment to 
others, thus providing a final indication of the success of the treatments being tested in this 
research study. 
7.2 Participant Learning 
 Counselling and allied therapies are often focussed upon the alleviation of some issue 
or problem which the client presents, which has been reported above. However, in this study, 
it is also worthwhile commenting upon the incidental learning that participants underwent. 
That is, each participant learnt how to observe and control their own HR and RSA, and 
thereby gained a sense of self-control and confidence which, although not measured as a 
defined outcome of the study, was voluntarily commented upon by almost all participants. As 
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has been noted in many clinical settings and with many disorders, the increase in participants‘ 
self-efficacy in regard to their ability to control some of their (previously uncontrollable) 
physiological responses to stress (i.e., HR, RSA) is a key aspect of generalising the kinds of 
learning that occurs within clinical settings to everyday life environments. Such increases in 
self-efficacy over what are most commonly referred to as ‗uncontrollable‘ parameters of 
physiological systems can provide a major boost to the self-esteem of people who (like those 
in this study) have an established history of self-perceived inadequacy in regard to controlling 
their own somatic responses to environmental stressors and threats. 
7.3  Implications for Counselling Practice 
 It is worthwhile commenting on another aspect of the outcomes of this study - that of 
the use of the Functional Assessment and BFB procedures in everyday Counselling settings. 
As mentioned during the introductory chapters, relatively few attempts have been reported in 
which Functional Assessment has been applied to the diagnosis and treatment of GAD. 
Although the present setting (i.e., a research study conducted in a university clinic) may have 
a greater degree of supervisory and clinical ability than is present in relatively isolated 
settings, the ease with which the Functional Assessment and BFB protocols were mastered 
and applied to participants by the therapist argues that they could also be similarly applied by 
other counselling professionals in the field. Although that process requires some further 
learning by practitioners, the consistency of participant outcomes in terms of RHR, RSA, 
SAS and related symptoms of GAD argues for the consideration of these techniques in 
everyday counselling practice for anxiety. Finally, it is of interest that this study did not focus 
upon previous life histories, use more complex counselling and psychotherapeutic techniques, 
nor spend a great deal of time with the participants. Although there is no attempt being made 
here to suggest that those processes are not valuable and required with some clients who 
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present with GAD, it is worthwhile commenting that they were not evidently necessary with 
these 11 participants.   
7.4  Limitations of the Study and Suggestions for Further Research 
 As a clinically-focussed study, this project suffers from the same limitations on 
generalisation that apply to any such studies. That is, there is no attempt made here to claim 
that these results compare with those from much larger studies that are group-based, and 
extension of these findings to such a comparison would enable greater generalisability to be 
established. Similarly, only a single therapist was used in this study, and therefore it was not 
possible to definitively claim that the positive outcomes were not influenced by ‗personal‘ 
variables surrounding the therapeutic relationship established by that therapist with the 11 
participants.  Use of multiple therapists in future studies would allow testing of the ‗therapist‘ 
effects. Although GAD is a very widespread disorder, it is not the only psychological 
disorder that is amenable to either Functional Assessment and/or BFB, and inclusion of other 
disorders (e.g., PTSD, Phobia, Depression) that are common within the non-hospitalised 
mental illness range could add to the data reported here.  Finally, as explained earlier, the 
separation of the three major treatments (BFB, Relaxation Training, Systematic 
Desensitization) was not undertaken for ethical reasons. It is not justifiable to provide less-
than-optimal treatment to people who seek treatment for their disorder, and therefore the 
issue of comparing these three aspects of the overall combined treatment package was not 
possible here. 
7.5 Conclusions 
 This study resulted in a consistent and clinically significant reduction in the symptoms 
of GAD across all 11 participants, plus reductions in elevated RHR and improvement in RSA, 
two established indicators of SNS hyperarousal. Because the results of the Functional 
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Assessment and HR training were so uniform across all participants, and because these 
therapeutic techniques are within the ability of professionally-trained counsellors, this study 
might be used as an argument for including such therapeutic techniques in courses which 
train counsellors and related personnel who aspire to assist people to deal with one of the 
most common and debilitating of non-hospitalised mental health problems. Generalised 
Anxiety Disorder that arises from environmental and historical events is common in many 
people and can contribute an unnecessary disease burden upon those who suffer from it, those 
who care from them, and the wider society that loses the talents of people who suffer from 
GAD. This study has demonstrated one method of alleviating that suffering in the counselling 
setting. 
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APPENDIX A 
Diagnostic Criteria for a Generalised Anxiety Disorder - DSM-IV-TR 
  
A. Excessive anxiety and worry (apprehensive expectation), occurring more days than not 
for at least 6 months, about a number of events or activities (such as work or school 
performance). 
         
B. The person finds it difficult to control the worry. 
 
C. The anxiety and worry are associated with three (or more) of the following six symptoms 
(with at least some symptoms present for more days than not for the past 6 months). 
NOTE: Only one item is required in children. 
 
1. Restlessness or feeling keyed up or on the edge.     
2. Being easily fatigued.      
3. Difficulty concentrating or mind going blank.  
4. Irritability.      
5. Muscle tension.      
6. Sleep disturbances.      
 
D. The focus of the anxiety and worry is not confined to features of an Axis I disorder:  
 
The anxiety or worry is not about having a Panic Attack (as in Panic Disorder)  
      Being embarrassed in public (as Social Phobia)   
      Being contaminated (as in Obsessive-Compulsive Disorder) 
Being away from home or close relatives (as in Separation Anxiety Disorder) 
Gaining weight (as in Anorexia Nervosa)  
Having multiple physical complaints (as in Somatisation Disorder) 
Having a serious illness (as in Hypochondriasis)  
The anxiety and worry do not occur exclusively during Post-Traumatic Stress 
      Disorder.       
 
E. The anxiety, worry or physical symptoms cause clinically significant distress or 
impairment in social, occupational or other important areas of functioning. 
 
F. The disturbance is not due to the direct physiological effects of: 
A substance (e.g. a drug of abuse, a medication)   
A general medical condition (e.g. hyperthyroidism)   
Does not occur exclusively during a Mood Disorder,  
a Psychotic Disorder or a  
Pervasive Developmental Disorder.  
 
 
 
 
   
 
 
 
109 
 
 
 
APPENDIX B 
Summary of Features for Anxiety Disorders 
Classification DSM-IV-TR 
Anxiety Disorders Psychological symptoms Physiological Symptoms Other 
Panic Disorder without Agoraphobia Derealisation, Depersonalisation 
Fear of Losing Control 
Fear of Dying 
Palpitations, Sweating, Trembling, 
Shortness of Breath, Feeling of Choking, 
Chest Pains, Nausea and Abdominal 
Distress, Dizziness, Paraesthesia, Chills 
and Hot Flushes 
Must be recurrent 
Not caused by medical conditions or 
substance use /abuse 
Not caused by any other mental disorder 
Panic Disorder with Agoraphobia As for Panic Disorder without 
Agoraphobia 
As for Panic Disorder without 
Agoraphobia 
Must be recurrent 
Not caused by medical conditions or 
substance use /abuse 
Not caused by any other mental disorder 
Anxiety about being in places or situations 
from which escape might be difficult or in 
which help may not be available 
Specific situations are avoided or severe 
distress/ panic attack 
Agoraphobia without a History of 
Panic Disorder 
No symptoms present to diagnose a 
Panic Disorder 
No symptoms present to diagnose a Panic 
Disorder 
Fear of developing panic-like symptoms 
Not caused by medical conditions or 
substance use /abuse 
Not caused by any other mental disorder 
Specific Phobia As for Panic Disorder without 
Agoraphobia 
As for Panic Disorder without 
Agoraphobia 
Marked and persistent fear that is excessive 
or unreasonable, cued by the presence or 
anticipation of a specific object or situation 
The person recognise the fear is excessive 
or unreasonable 
The phobic situation is avoided or intense 
anxiety is present when faced with 
situations 
The avoidance significantly interferes with 
their normal routine 
Not caused by medical conditions or 
substance use /abuse 
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Not caused by any other mental disorder 
Social Phobia As for Panic Disorder without 
Agoraphobia 
As for Panic Disorder without 
Agoraphobia 
Marked and persistent fear of one or more 
social or performance situations 
Exposure to the situation provokes anxiety 
The person recognise the fear is excessive 
or unreasonable 
The situation is avoided 
The avoidance significantly interferes with 
the persons normal routine 
Not caused by medical conditions or 
substance use /abuse 
Not caused by any other mental disorder 
Obsessive-Compulsive Disorder As for Panic Disorder without 
Agoraphobia 
As for Panic Disorder without 
Agoraphobia 
Recurrent obsessions/compulsions 
The person recognises that the obsessions/ 
compulsions are excessive 
The obsessions/compulsions caused 
marked distress and interferes with the 
person‘s normal routine 
Not caused by medical conditions or 
substance use /abuse 
Not caused by any other mental disorder 
Post-Traumatic Stress Disorder Recurrent intrusive thoughts 
Recurrent distressing dreams 
Intense psychological distress 
Difficulty concentrating 
Physiological reactivity 
Persistent symptoms of insomnia, 
irritability or anger 
Hypervigilance 
Exaggerated startle response 
The person has been exposed to a traumatic 
event which threatened death or serious 
injury 
The person‘s response involves intense 
fear, helplessness or horror 
Acting and feeling as if the traumatic event 
was reoccurring 
Persistent avoidance of stimuli associated 
with the event 
The symptoms significantly interfere with 
the person‘s normal routine  
Acute stress Disorder Subjective sense of numbing 
Detachment or absence of emotional 
responsiveness 
Reduction of awareness of surroundings 
Derealisation, depersonalisation 
Dissociative amnesia 
Increased arousal 
Difficulty sleeping 
Irritability 
Hypervigilance 
Exaggerated startle response 
Motor restlessness 
The person re-experience the traumatic 
event with recurrent images, thoughts, 
dreams, illusions, flashback episodes or a 
sense of reliving the experience 
Marked avoidance of stimuli that arouse 
recollection to the trauma 
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The symptoms significantly interfere with 
the person‘s normal routine 
Not caused by medical conditions or 
substance use /abuse 
Not caused by any other mental disorder 
Generalised Anxiety Disorder Difficulty in controlling worry 
Easily fatigued 
Difficulty in concentrating  
Restlessness 
Irritability 
Muscle tension 
Sleep Disturbances; insomnia, restless 
sleep 
Excessive anxiety and worry  
The worry or anxiety significantly interfere 
with the person‘s normal routine 
Not caused by medical conditions or 
substance use /abuse 
Not caused by any other mental disorder 
Anxiety Disorder due to a Medical 
Condition 
As for Panic Disorder without 
Agoraphobia 
As for Panic Disorder without 
Agoraphobia 
History, physical or laboratory findings of 
a medical condition 
The disturbance does not occur exclusively 
during the course of delirium 
The disturbance significantly interferes 
with the person‘s normal routine 
Substance-Induced Anxiety Disorder As for Panic Disorder without 
Agoraphobia 
As for Panic Disorder without 
Agoraphobia 
History, physical or laboratory findings of 
intoxication or withdrawal or medication 
use etiology related to the disturbance 
The disturbance does not occur exclusively 
during the course of delirium 
The disturbance significantly interferes 
with the person‘s normal routine 
Anxiety Disorder NOS As for Panic Disorder without 
Agoraphobia 
As for Panic Disorder without 
Agoraphobia 
Mixed anxiety-depressive disorder 
Clinical significant social phobia due to a 
general medical  or mental disorder 
Situations where the disturbance is severe 
enough but the individual fails to report 
enough symptoms for a specific anxiety 
disorder 
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APPENDIX C 
Level 5 Efficacy for Biofeedback 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Author/s Year Participants Diagnosis Modalities Treatment outcomes 
Susset, J. G., Galea, G.,  
& Read, L. 
1990 Women from Veterans  
Administration - Brown  
University Medical School 
Rhode Island 
15 participants 
Urinary 
incontinence 
Intravaginal probe biofeedback Significant improvement 
proven 
12 women had 100% 
subjective and objective 
improvement. 
2 women had 65-75% 
improvement. 
1 woman failed to respond. 
Burgio K. L., Whitehead 
W. E., & Engel B., T. 
1985 Community members 
39 participants 
 
 
1. Stress 
incontinence 
2. Detrusor 
motor instability 
3. Urge 
incontinence 
Biofeedback measurements - 14 
French catheter and 
rectal biofeedback tubes 
Significant improvement 
proven. 
81.7 % improvement in 
symptoms. 
85% improvement in 
symptoms. 
94.4% improvement in 
symptoms. 
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APPENDIX D 
Level 4 Efficacy for Biofeedback 
 
Author/s Year Participants Diagnosis Modalities Treatment outcomes 
Garrett B.L., & Silver 
M.P. 
1976 Enrolled college students 
50 divided in 5 groups 
Anxiety 
disorder 
Randomised control study 
1. Alpha enhancement 
2. EMG voltage reduction 
3. Alpha enhancement + 
EMG voltage reduction 
4. Relaxation training 
5. No treatment 
Only participants in the 3 
feedback groups 
reported significant 
reduction in test anxiety 
suggesting that 
improvements were not due  
to passage of time or non-
specific factors. 
Rice K.M., Blanchard E. 
B., 
& Purcell M. 
1993 Students and staff from 
SUNY-Albany and  
community members 
45 participants 
GAD 1. Frontal EMG Biofeedback 
2. Alpha Enhancement Biofeedback 
3.Alpha suppressant biofeedback 
4. Psuedomeditation 
The EEG alpha increase 
biofeedback group  
 showed significant 
reduction in heart rate 
The EMG biofeedback 
groups showed significant  
clinical improvements in 
STAI-Trait scores. 
Vanathy S., Sharma P. S. 
V. N., & Kumar K. B. 
1998 Community members 
18 participants 
GAD 1. Waiting list 
2. Alpha enhancement/ Beta 
suppressant protocol 
3. Theta enhancement/ / Beta 
suppressant protocol 
Improvement in both 
treatment groups relative to  
the untreated control group. 
Hitanshu A., Maman P., 
& 
Jaspal S.S. 
2008 Community members 
45 participants 
GAD 1. EMG biofeedback 
2. EEG biofeedback 
3. Control group 
Significant reduction in both 
treatment groups 
relative to the untreated 
control group 
EMG group was the most 
effective treatment. 
Romano, J.L. 1978 Students from the College 
of Education 
40 participants 
Anxiety 
disorder 
1. EMG Assisted Systematic 
Desensitization 
2. EMG Relaxation Training 
3. Automated Systematic 
Desensitization 
No significant difference 
between treatment  efficacy  
in all 3 groups. 
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Bradley R. T., McCraty 
R.,  
Atkinson M., Tomasino 
D.,  
Daugherty A.,  & 
Arguelles L. 
2010 10th grade students from 
Two schools in Northern 
Carolina 
136 participants 
Healthy 
individuals but 
exposed to 
stressors 
causing anxiety 
1. TestEdge program with 
Psychophysiological  
Feedback 
2. Control group 
Significant difference in the 
reduction of test anxiety in 
the treatment group in 
relation to the control group. 
 
Hendriques G.,  Keffer 
S., 
Abrahamson C.,  & 
Horst S.J. 
2011 First year Psychology  
Students  
Study 1 
9 participants 
Study 2  
35 participants 
GAD HRV Significant  reduction in 
anxiety levels due to 
biofeedback 
training. 
Masafi S., Rezaei O., &  
Ahadi H. 
2011 Women from Emam 
Khomeimi Hospital 
14 participants 
Anxiety 
Disorder 
1. Biofeedback training group 
2. Control group 
There was a significant 
deference between 
experiment  
 and control groups pre- and 
post-tests 
Biofeedback associated with 
relaxation was effective in  
decreasing state anxiety. 
 
Blanchard E. B., Eisele 
G.,  
Vollmer A., Payne A.,  
Gordon M., Cornish P., 
& 
Gilmore L. 
1996 Community members 
42 participants 
Mild 
hypertension 
1. Thermal Biofeedback Training 
2. Blood pressure monitoring at home 
57.1% lowering blood 
pressure to normal levels. 
33% lowering blood 
pressure to normal levels. 
Nakao M. 2000 Community members 
Harvard University 
students 
38 participants 
1. White-coat 
hypertension 
2  Essential 
hypertension 
3. Control group 
Biofeedback Training 
Biofeedback Training 
No treatment 
Reduction in blood pressure 
22/11 mmHG 
Reduction in blood pressure 
14/8 mmHG 
No reduction in blood 
pressure. 
Thompson L., & 
Thompson M. 
2005 Meta-Analysis ADHD Neurofeedback (EEG biofeedback) Significant improvement in 
listening skills, memory, 
focus and following through 
on completing tasks. 
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Schwartz M.S. & 
Andrasik F. 
2003 Meta-Analysis Various types of 
headaches 
All biofeedback modalities Effective treatment for 
muscle tension headaches, 
psychogenic headaches, 
vascular headaches, 
migraines, combination 
headaches and mixed 
headaches. 
Andrasik F. 2003 Comparative study Various types of 
headaches 
Biofeedback training 
Relaxation training 
CBT 
Efficacy proven in Chronic 
daily high intensity 
headaches,  
refractory headaches, cluster 
headaches, chronic tension 
headaches, post-traumatic 
headaches, psychiatric co  
morbidity,  and chronic pain 
traps. 
Jensen M.P., Gertz K.J.,  
Kupper A.E., Braden 
A.L.,  
Howe J.D., Hakimian S.,  
& Sherlin L.H. 
2013 Community members 
10 participants 
Chronic pain 
with spinal cord 
injury 
Neurofeedback 
Pain intensity 
Sleep quality 
Decrease in chronic pain 
with statistically significant 
reduction in pain intensity. 
Wahbeh H., & Oken B.S. 2012 Community members from 
Portland Veterans 
Administration 
Medical Centre 
86 participants 
59 with PTSD 
27 without 
PTSD 
EEG Feedback 
HRV 
Respiration rate 
PTSD group had more 
statistically significant 
treatment changes than non 
PTSD group. 
Bornas X., Riera del 
Amo A.,  
Tortella-Feliu M., & 
Llabres J 
2012 Community members 
45 participants 
Flight phobia HRV Treatment study reports high 
or acceptable rate of success. 
Hammer B.U., Colbert 
A.P., 
Brown K.A., & Ilioi E.C. 
2011 Community members from  
Portland, Oregon 
8 participants 
Insomnia Neurofeedback SMR neurofeedback reduces 
insomnia 
 
 
 
 
116 
 
 
 
APPENDIX E 
 
Inclusion/Exclusion Criteria 
 
 
Participant Age Gender Class Diagnosis of 
GAD 
Health Exclusions Medication Illicit Drug Use 
1 18 F Student Yes No No No 
2 53 M Lecturer Yes No No No 
3 20 F Student Yes No No No 
4 57 M Lecturer Yes No No No 
5 39 F Lecturer Yes No No No 
6 28 M Student Yes No No No 
7 24 F Student Yes No No No 
8 32 F General Staff Yes No No No 
9 23 F Student Yes No No No 
10 30 F General Staff Yes No No No 
11 46 M Student Yes No No No 
12 23 F Student PTSD No No No 
13 26 M General Staff Social Phobia No No No 
14 29 F General Staff Yes No Beta blockers No 
15 20 F Student Yes No No Cannabis 
16 45 F Lecturer Yes Myocardial infarction No No 
17 32 F General Staff Yes Hyperthyroidism  Thyroxin No 
18 19 M Student OCD No No No 
19 21 F Student PTSD No No No 
20 20 M Student Yes Yes No Amphetamines 
21 20 F Student Yes Yes Benzodiazepines No 
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APPENDIX F 
 
Interview Schedule 
 
 
The interview will be adapted to the individual client‘s needs. The following questions are 
included in order to obtain data for the Functional Analysis. 
 
1. Client’s biographical details: 
    Name:   
_________________________________________________________________        
       Date of birth:   
_________________________________________________________________ 
       Sex:    
_________________________________________________________________ 
       Address:  
_________________________________________________________________ 
         _________________________________________________________________ 
           _________________________________________________________________ 
       Phone:   
_________________________________________________________________ 
      Occupation:   
_________________________________________________________________ 
 
 
    2. Family history: 
 Married, de-facto, single, widowed, divorced or separated: 
_________________________________________________________________ 
 Number of children:  
_________________________________________________________________ 
 
 
     3. Medical history: 
 Existing medical condition(s):  
_________________________________________________________________ 
 Current medication(s):  
_________________________________________________________________ 
 Previous medical condition(s):  
_________________________________________________________________ 
 Previous psychological condition(s):  
_________________________________________________________________ 
 Family history of medical/psychological condition(s):  
_________________________________________________________________ 
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       4. History of professional assistance:  
 _________________________________________________________________ 
 _________________________________________________________________ 
_________________________________________________________________ 
        
 
      5. Presenting problem: 
          (In clients, own words) 
            _________________________________________________________________ 
            _________________________________________________________________ 
 _________________________________________________________________ 
      _________________________________________________________________ 
 
 
      6. Behavioural difficulties as expressed by the client: 
            _________________________________________________________________ 
            _________________________________________________________________ 
            _________________________________________________________________ 
            _________________________________________________________________ 
 
 
7. Length of time the behaviour has been a concern to or limiting factors in the 
client’s life: 
      _________________________________________________________________ 
 
 
       8. Possible maintaining conditions: 
  Location or setting in which the behaviour occurs:  
_________________________________________________________________ 
            _________________________________________________________________ 
 Times at which the behaviour occurs:  
_________________________________________________________________ 
            _________________________________________________________________ 
 Activity undertaken when the behaviour occurs:  
_________________________________________________________________ 
            _________________________________________________________________ 
 People present when the behaviour occurs:  
_________________________________________________________________ 
            _________________________________________________________________ 
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        9. Form analysis: 
 Dimensions of the anxiety related behaviour: 
 Duration:  
___________________________________________________________ 
 Frequency:  
___________________________________________________________ 
  Latency:  
___________________________________________________________ 
  Magnitude:  
___________________________________________________________ 
       
      10. Functional assessment: 
 Setting events:  
__________________________________________________________________ 
__________________________________________________________________ 
  
 Proximal antecedents:  
__________________________________________________________________ 
 __________________________________________________________________ 
 
  Setting:  
____________________________________________________________ 
  Interactions: 
____________________________________________________________ 
  Tasks:  
____________________________________________________________ 
  
 
     11. Post-behaviour maintaining variables: 
 Immediate consequences: 
  Positive reinforcements:  
____________________________________________________________ 
____________________________________________________________ 
  Negative reinforcements: 
_______________________________________________________________
_________________________________________________________ 
 
 Delayed consequences: 
 
  Positive reinforcement:  
____________________________________________________________ 
____________________________________________________________ 
  Negative reinforcement: 
____________________________________________________________ 
  ____________________________________________________________ 
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12. Functions for GAD  
Are any of the following factors present?  
  
Function Label Participant Self-Report Experience 
Escape   
Sensory reinforcement   
Avoidance of social context   
Attention   
Change to reactions of others   
Access to preferred Activity   
Internal change   
Internal state - psychological change   
 
 
 
 
Diagnostic Criteria for a Generalised Anxiety Disorder - DSM-IV-TR. 
  
A. Excessive anxiety and worry occurring more days than not for at least 6 months, about a 
number of events or activities (such as work or school performance). 
 
Criterion A      YES  NO 
 
B. The person finds it difficult to control the worry. 
 
 
Criterion B      YES   NO 
 
C. The anxiety and worry are associated with three (or more) of the following six symptoms 
(with at least some symptoms present for more days than not for the past 6 months). 
7. Restlessness or feeling keyed up or on the edge.    YES             NO 
8. Being easily fatigued.     YES  NO 
9. Difficulty concentrating or mind going blank. YES  NO 
10. Irritability.      YES  NO 
11. Muscle tension.     YES   NO 
12. Sleep disturbances.     YES  NO 
 
 
Criterion C      YES  NO 
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D. The focus of the anxiety and worry is not confined to features of an Axis I disorder:  
 
The anxiety or worry is not about having a Panic Attack (as in Panic Disorder)  
YES               NO 
      Being embarrassed in public (as Social Phobia)  YES  NO  
      Being contaminated (as in Obsessive-Compulsive Disorder) 
 YES  NO 
Being away from home or close relatives (as in Separation Anxiety Disorder) 
        YES  NO 
Gaining weight (as in Anorexia Nervosa)  YES  NO 
 Having multiple physical complaints (as in Somatisation Disorder) 
        YES  NO 
 Having a serious illness (as in Hypochondriasis) YES  NO 
 The anxiety and worry do not occur exclusively during Post-Traumatic Stress 
       Disorder.       YES  NO 
 
       Criterion D      YES   NO 
 
E. The anxiety, worry or physical symptoms cause clinically significant distress or 
impairment in social, occupational or other important areas of functioning. 
 
      Criterion E      YES  NO 
 
F. The disturbance is not due to the direct physiological effects of: 
A substance (e.g. a drug of abuse, a medication)  YES  NO 
A general medical condition (e.g. hyperthyroidism)  YES  NO 
 
Does not occur exclusively during a Mood Disorder,  
a Psychotic Disorder or a  
Pervasive Developmental Disorder.   YES  NO 
 
Criterion F      YES  NO 
 
 
Does the client meet the criteria for a Generalised Anxiety Disorder? 
 
        YES  NO 
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APPENDIX G 
 
 
Problems  
with anxiety in  
daily life? 
 
Participate in this new project! 
 
The research will be conducted by Dr Phillip Fourie at the School of Health 
Science at Bond University. All sessions are held during office hours. 
 
This study will help me to analyse and understand anxiety and anxiety-related behaviour and 
to find more effective treatment for clients suffering from general anxiety. 
 
The study consists of two stages: 
 
Stage one:    One or two one-hour interview session(s) at the School of Health  
           Sciences, Bond University. This will be an interview to collect data  
           regarding anxiety and anxiety-related symptoms. 
Stage two:    Four to five one-hour treatment sessions for anxiety-related 
          problems.  
 
During stage one data will be collected (This stage has no therapeutic intent) and 
treatment will only start in stage two of this study. 
 
If you are interested please call 07-5595 4171 or return my e-mail: 
pfourie@staff.bond.edu.au and leave your name and contact number 
and I will get back to you with details.    
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APPENDIX H 
 
Intake Form 
 
 
The interview will be adapted to the individual client‘s needs. The following questions are 
included in order to obtain data for the Functional Analysis. 
 
 
1. Client’s biographical details: 
 
    Name:   
_________________________________________________________________        
       Date of birth:   
_________________________________________________________________ 
       Sex:    
_________________________________________________________________ 
       Address:  
_________________________________________________________________ 
         _________________________________________________________________ 
           _________________________________________________________________ 
       Phone:   
_________________________________________________________________ 
      Occupation:   
_________________________________________________________________ 
 
 
 
2. Family history: 
 
 Married, de-facto, single, widowed, divorced or separated: 
_________________________________________________________________ 
 Number of children:  
_________________________________________________________________ 
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3. Medical history: 
 
 Existing medical condition(s):  
_________________________________________________________________ 
 Current medication(s):  
_________________________________________________________________ 
 Previous medical condition(s):  
_________________________________________________________________ 
 Previous psychological condition(s):  
_________________________________________________________________ 
 Family history of medical/psychological condition(s):  
_________________________________________________________________ 
 
 
       4. History of professional assistance:  
 _________________________________________________________________ 
 _________________________________________________________________ 
_________________________________________________________________ 
        
 
      5. Presenting problem: 
          
            _________________________________________________________________ 
            _________________________________________________________________ 
 _________________________________________________________________ 
      _________________________________________________________________ 
 
 
I acknowledge that all information on this form will be treated as confidential information at 
all times. 
 
 
Signed: ______________________              Dated: ________________________ 
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APPENDIX I 
 
 
Explanatory Statement 
Stage 1 
School of Health Science 
Dear Sir/Madam 
 
I am conducting a study, ―An evaluation of Functional Assessment and Biofeedback for the 
Treatment of Generalised Anxiety Disorder‖, project number: R0224, to help me understand 
anxiety and anxiety-related behaviour and to find more effective treatment for clients 
suffering from anxiety. 
 
The first stage of this study would involve one or two formal interview(s) of approximately 
one hour each. These interviews will be conducted at the School of Health Sciences, Bond 
University. During these interviews, information will be gathered in relation to the reason(s) 
that caused the anxiety and the duration of the anxiety-related symptoms and the specific 
behaviour that developed because of the anxiety. Please note that Stage 1 has no therapeutic 
intent. The information from this interview would be analysed for the second stage of the 
study.  
 
The research is conducted for a thesis for a Doctorate of Counseling, under the supervision of 
Professor Chris Sharpley and Associate Professor Vicki Bitsika.  
 
The collected data is treated with the strictest confidentiality and will be secured in locked 
premises after completion of the project. Only researchers taking part in the study will have 
access to the data. Your name will be on the data collected in stage one but the final report 
contains summarized findings and individual results will remain anonymous. 
 
Your participation would be highly appreciated. However, you are under no obligation to do 
so. If at any stage during the course of the study you no longer wish to participate, you are 
free to withdraw consent. 
Please sign and date the attached form if you agree to participate. 
 
If any problems occur during the research, the Complaints Officer, Jodie Maguire can be 
contacted at Bond University, telephone: 07-5595 4001. 
 
If you require any further information, do not hesitate to contact me on 5595 4171. 
 
Yours truly, 
 
 
Phillip Fourie 
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APPENDIX J 
 
 
 
     Consent Form 
 
 
Research Title: An evaluation of Functional Assessment and Biofeedback for the Treatment 
of Generalised Anxiety Disorder. 
Project number: R0244 
 
Principal investigator:  Professor Chris Sharpley. 
Associate investigator: Doctor Phillip Fourie. 
 
I, ……………………….. have read the information provided and understand the  
                    (Full Name) 
requirements of this study. 
 
 
I agree to participate under the following terms: 
 
1. I have read the explanatory information associated with this consent form and  
      agree to requirements contained therein. 
2. I am free to withdraw from this study at any time, without any repercussions. 
3. My anonymity will be maintained in any publication. 
4. Any data I provide will be confidential and access will be restricted to the 
researchers. 
 
 
Name:       ___________________________________ (please print) 
 
 
 
Signature: ____________________                        Date: ______________ 
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APPENDIX K 
Zung Anxiety Scale 
 
Question None or a 
little of the 
time 
Some of the 
time 
Good part of 
the time 
Most or all 
of the time 
1. I feel more nervous and 
anxious than usual. 
    
2. I feel afraid for no reason at 
all. 
    
3. I get upset easily or feel 
panicky. 
    
4. I feel like I am falling apart 
and going to pieces. 
    
5. I feel that everything is all 
right and nothing bad will 
happen. 
    
6. My arms and legs shake and 
tremble. 
    
7. I am bothered by headaches, 
neck and back pains. 
    
8. I feel weak and get tired 
easily. 
    
9. I feel calm and can sit still 
easily. 
    
10. I can feel my heart beating 
fast. 
    
11. I am bothered by dizzy 
spells. 
    
12. I have fainting spells or feel 
like it. 
    
13. I can breathe in and out 
easily. 
    
14. I get feelings of numbness 
and tingling in my fingers and 
toes. 
    
15. I am bothered by stomach 
aches or indigestion. 
    
16. I have to empty my bladder 
often. 
    
17. My hands are usually dry 
and warm. 
    
18. My face gets hot and 
blushes. 
    
19. I fall asleep easily and get a 
good night’s rest. 
    
20. I have nightmares. 
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APPENDIX L 
Progressive Muscle Relaxation (PMR) 
 
PMR can be done by physically contracting the muscles/muscle groups or by focussing on or 
visualizing the specific muscle/muscle group and then to relax it. 
 
The idea is to override the autonomic nervous system (sympathetic part) and voluntary taking 
control of muscle tension/tonus. 
 
Be careful! If any part of your body is injured or has a weak area, only do visualization of 
that specific part.  
 
Always remember to start with diaphragmatic breathing for a couple of minutes (as 
demonstrated and practiced during the session) and then do the PMR. 
I prefer to start as far away from the central nervous system (brain) as possible. 
 
Please follow the instructions below: 
1. Toes – flex and extend your toes. 
2. Arch the bridge of your feet and relax. 
3. Ankles- flex and extend your ankles. 
4. Contract your calf muscles and relax. 
5. Contract and relax your upper legs. 
6. Pull your pelvis in and relax. 
7. Clench your gluteus muscle (back side) and relax. 
8. Pull your abdomen in and relax. 
9. Arch your lower back and relax (only if you do not have any back problems!) 
10. Contract and relax your pectoral muscles (chest). 
11. Form fists with your hands and relax. 
12. Flex and extend your wrists. 
13. Turn your forearms to one side then to the other (pronation and supination). 
14. Flex and relax your biceps (front of upper arm). 
15. Extend and relax you triceps (back of upper arm). 
16. Pull your shoulders backwards. 
17. Pull your shoulders forwards. 
18. Pull your shoulders upwards. (towards your ears). 
19. Put your chin on your chest (if you do not suffer from neck problems!) 
20. Move your head to the left and relax. 
21. Move your head to the right and relax. 
22. Press your lips together and relax. 
23. Close your eyes tight and relax. 
24. Just relax and focus on breathing. 
Remember to focus regularly on diaphragmatic breathing! 
Do these exercises very slowly – approx. 20-30 minutes. 
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APPENDIX M 
 
Treatment Regime by Sessions 
Session Purpose Activity 
I Orientation of participants and 
detailed explanation of study 
procedures. 
Potential participants were greeted at the clinic by the 
receptionist. 
The receptionist provided each participant with a hard copy of 
the Intake Form and requested that (s)he complete it (Appendix 
H). 
The researcher introduced himself to the potential participant 
once the Intake Form was completed.  
The potential participant was taken to the consultation room 
begin the process of orienting him/her the study objectives and 
requirements. 
The inclusion criteria for the study were explained to the 
potential participant and the researcher checked that (s)he was 
willing to proceed with the session on the understanding that, if 
inclusion criteria were not met, the person would not be able to 
take part in the study. 
The two stages of the study were explained to the potential 
participant. The Explanatory Statement for Stage I was handed 
to him/her and the researcher requested that (s)he read the 
statement in his presence in order to gain clarification (if needed) 
and to re-state willingness to participate in the study after having 
reviewed study requirements a second time (Appendix I). 
After the potential participant read the Explanatory Statement for 
Stage I, (s)he was asked to sign the Consent form to confirm 
his/her intention to continue with the study (Appendix J). 
The Zung SAS was administered to the participant as part of the 
Functional Assessment and as a pre intervention measure for 
anxiety severity. 
An Intake Interview was conducted to gather biographical 
information and explore for the possible presence of GAD as 
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determined by the DSM-IV-TR diagnostic criteria (Appendix 
A).  
The potential participant was asked to make a follow-up 
appointment the following week. 
Session duration = 1 hour. 
II Idiographic assessment of 
anxiety in relation to 
investigation of fear response 
and its maintaining variables. 
The Intake Interview was continued to collect further 
information that allowed for a final check on the accuracy of 
researcher notes on anxiety symptomatology. This procedure 
was followed to confirm or reject the presence of GAD. This 
interview was also used to conduct a functional assessment of 
each participant‘s anxiety-based behaviours and the impacts of 
those on day-to-day functioning (Appendix F).  
If the participant met the inclusion criteria for this study, (s)he 
was invited to continue with Stage 2. 
If the potential participant did not meet the criteria for this study, 
(s)he was offered alternative counselling by the researcher or 
(s)he was given 2-3 other counsellor‘s contact details and a 
referral letter. 
The Explanatory Form, Stage II was handed and explained to the 
participant (Appendix N). 
The participant was asked to make a follow-up appointment the 
following week. 
Session Duration: 1 hour. 
The Functional Assessment data were analysed between sessions II and III to determine fear response 
topography, setting and antecedent events which acted as triggers for the fear response, reinforcement 
processes which strengthened the fear response, and the functions which made the fear response adaptive. 
III Introduce biofeedback training. The researcher familiarised each participant with the 
Biofeedback equipment (Bioview series IV, Zencor®) by 
explaining and demonstrating its functions and the locations of 
placement of electrodes. Participants were also shown, on a 
computer screen, examples of the RSA and Heart Rate graphs 
generated by collecting physiological data from them in this 
preliminary trial. 
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The researcher initiated the first Biofeedback session (i.e., base-
line data collection [Heart Rate and RSA]) whilst discussing an 
anxiety-provoking incident with the participant. Descriptions of 
the anxiety-provoking incident were obtained from the 
Functional Assessment data. 
Biofeedback Session Duration = 10 minutes. 
The researcher explained the respiration-based training process 
via Respiratory Sinus Arrhythmia Feedback (RSAFB) to the 
participant. 
The participant was familiarised with the type of feedback (s)he 
would be receiving during RSABF by viewing the computer 
screen on which his/her heart rate plots were shown. The 
researcher also demonstrated how he/she could increase the 
amplitude of his/her Respiratory Sinus Arrhythmia (RSA) by 
performing diaphragmatic breathing via an audio response. 
The participant was asked to practice respiration-based training 
at home for 10 minutes twice daily over a one week period to 
assist him/her in becoming accustomed to diaphragmatic 
breathing. 
The participant was asked to make a follow-up appointment the 
following week. 
Session Duration = 45 minutes 
IV Biofeedback training plus 
Visualisation. 
Brief Biofeedback training of approximately 10 minutes was 
done to review the RSAFB while doing diaphragmatic breathing. 
If needed, the breathing technique was refined by explaining the 
procedure for a second time and practising the procedure until 
the participant mastered the technique. 
Visualisation was utilised in two ways. First, visualisation of an 
anxiety-provoking event with the instruction to the participant to 
focus on its neutral features was used to shape distraction from 
the threatening features of that event. Second, visualisation of a 
calm environment in which the participant felt secure.  
The participant was shown (via plots on the computer screen) 
132 
 
 
 
how the two aspects (i.e., anxiety-provoking event versus calm 
environment) of this visualisation technique influenced his/her 
RSA amplitude. 
The participant was asked to practice both the respiration-based 
training and the visualisation techniques at home, for 20 minutes 
per day for one week. 
The participant was asked to make a follow-up appointment the 
next week. 
Session Duration = 1 hour.  
V Pair biofeedback training plus 
Progressive Muscle Relaxation 
(PMR). 
Brief Biofeedback training of approximately 15 minutes was 
employed to review RSAFB while doing diaphragmatic 
breathing and the visualisation technique. If needed the 
techniques were refined via additional explanation and 
demonstration. 
PMR was introduced as the basis for assisting the participant to 
discriminate between subjective feelings of muscle tension and 
muscle relaxation (Appendix L). 
While the participant was guided through the PMR process in a 
stepwise manner, (s)he was also instructed to view how this 
technique was affecting his/her RSA amplitude on the computer 
screen. Audio cues were also used to assist in building 
participant focus on reactivity changes. 
The participant was asked to make a follow-up appointment in 
two weeks. 
Session Duration = 1 hour 
 
VI Pair biofeedback training plus 
exposure to tailored Systematic 
Desensitisation. 
Biofeedback training of approximately 20 minutes was 
conducted to review RSAFB while doing diaphragmatic 
breathing, visualisation technique and PMR. If needed, these 
techniques were refined via active practice and explanation. 
Systemic Desensitization was applied to assist participants in 
learning a non-anxious response to compete with and 
eventually replace anxious behaviour. The competing response, 
primarily focused on creating positive internal change, was 
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shaped and reinforced over sessions via introduction of a 
participant-specific anxiety hierarchy with data obtained from 
the Functional Assessment. In order to ensure consistency 
across all participants, the anxiety hierarchy contained 
consistent features which included: only five-seven anxiety 
provoking events, a SUDS rating system which extended across 
1 – 100 units, emphasis of the key aversive features of each 
anxiety-provoking event, and termination of hierarchy exposure 
at the anxiety-provoking event for which successful anxiety 
reduction was achieved. 
The participant was verbally guided through the anxiety 
hierarchy and instructed to apply session III-V techniques to 
minimise any escalation in anxiety. (S)he received feedback via 
audio and RSAFB plots shown on the computer screen. 
The participant was then instructed to apply those techniques 
(s)he believed to be most effective in controlling his/her able 
RSA amplitude and therefore anxiety level in response to  
imagining a highly aversive anxiety-provoking event(s). 
The participant was instructed to practice learned techniques at 
home, at least once a day for 30 minutes per session. 
The participant was asked to make a follow-up appointment in 
two weeks. 
Session Duration = 1 hour. 
 
VII  Biofeedback training plus all 
learned technique 
 
 
 
Biofeedback training of approximately 30 minutes was 
conducted to review the participant‘s capacity to apply the 
techniques learned during sessions III – VI. 
The participant was instructed to apply those techniques during 
exposure to a highly anxiety-provoking event to exert control 
over his/her RSA and heart rate and therefore anxiety. Audio 
and visual RSAFB was provided. 
The participant was asked to complete the Zung Anxiety Scale 
as a post intervention measure of anxiety level (Appendix K). 
Session Duration = 1 hour. 
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APPENDIX N 
 
 
 
Explanatory Statement 
Stage 2 
 
School of Health Science 
Dear Sir/Madam 
 
I am conducting a study, ―An evaluation of Functional Analytic Therapy for Generalised 
Anxiety Disorder‖, project number: R0224, to help me understand anxiety and anxiety-
related behaviour and to find more effective treatment for clients suffering from anxiety. 
 
The second stage of my study consists of 4-5 one-hour counselling sessions. These sessions 
will take place at the Institute for Health Sciences at Bond University. During these sessions, 
I will use the information gained from the first stage of the study to develop a treatment plan 
that will be aimed to deal with the anxiety you experience and to help you to develop 
alternative coping skills to deal with this. This therapy will consist of relaxation therapy, 
biofeedback and respiration-based training, depending on your needs. 
 
The research is conducted for a thesis for a Doctorate of Counseling, under the supervision of 
Professor Chris Sharpley.  
 
The collected data is treated with the strictest confidentiality and will be secured in locked 
premises after completion of the project. Only researchers taking part in the study will have 
access to the data. Your name will be on your personal file but the final report contains 
summarized findings and individual results will remain anonymous. 
 
Your participation would be highly appreciated. However, you are under no obligation to do 
so. If at any stage during the course of the study you no longer wish to participate, you are 
free to withdraw consent. 
Please sign and date the attached form if you agree to participate. 
 
If any problems occur during the research, the Complaints Officer, Jodie Maguire can be 
contacted at Bond University, telephone: 07-5595 4001. 
 
If you require any further information, do not hesitate to contact me on 5595 4171. 
 
Yours truly, 
 
 
Phillip Fourie  
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